{"text_format":"3","workbook":"xlsx","n_sheets":55,"sheets":["Cover","CONDENSED CONSOLIDATED BALANCE ","CONDENSED CONSOLIDATED BALANC_2","CONDENSED CONSOLIDATED STATEMEN","CONDENSED CONSOLIDATED STATEM_2","CONDENSED CONSOLIDATED STATEM_3","CONDENSED CONSOLIDATED STATEM_4","CONDENSED CONSOLIDATED STATEM_5","CONDENSED CONSOLIDATED STATEM_6","Summary of Business and Signifi","Revenue","Fair Value Measurements","Cash Equivalents and Marketable","Balance Sheet Details","Commitments and Contingencies","Stockholders' Equity","Stock-Based Compensation","Income Taxes","Net Loss Per Share Attributable","Related Party Transactions","Pay vs Performance Disclosure","Insider Trading Arrangements","Summary of Business and Signi_2","Revenue (Tables)","Fair Value Measurements (Tables","Cash Equivalents and Marketab_2","Balance Sheet Details (Tables)","Stock-Based Compensation (Table","Net Loss Per Share Attributab_2","Revenue - Disaggregated Revenue","Revenue - Professional Services","Revenue - Deferred Revenue (Det","Revenue - Remaining Performance","Revenue - Customer Concentratio","Fair Value Measurements - Asset","Cash Equivalents and Marketab_3","Cash Equivalents and Marketab_4","Cash Equivalents and Marketab_5","Cash Equivalents and Marketab_6","Balance Sheet Details - Propert","Balance Sheet Details - Narrati","Balance Sheet Details - Accrued","Balance Sheet Details - Accru_2","Commitments and Contingencies (","Stockholders' Equity (Details)","Stock-Based Compensation - Narr","Stock-Based Compensation - Stoc","Stock-Based Compensation - Valu","Stock-Based Compensation - Rest","Stock-Based Compensation - Va_2","Stock-Based Compensation - St_2","Income Taxes (Details)","Net Loss Per Share Attributab_3","Net Loss Per Share Attributab_4","Related Party Transactions (Det"],"read":"whole","date_system":"1900"}

{"sheet":"Cover","index":0,"n_rows":37,"n_cols":3,"rows_kept":37,"merged":[[0,0,1,0]]}
["Cover - shares","9 Months Ended"]
[null,"Jan. 31, 2025","Feb. 20, 2025"]
["Document Information [Line Items]"," "," "]
["Document Type","10-Q"," "]
["Document Quarterly Report","true"," "]
["Document Period End Date","Jan. 31,  2025"," "]
["Document Transition Report","false"," "]
["Entity File Number","001-39744"," "]
["Entity Registrant Name","C3.ai, Inc."," "]
["Entity Incorporation, State or Country Code","DE"," "]
["Entity Tax Identification Number","26-3999357"," "]
["Entity Address, Address Line One","1400 Seaport Blvd"," "]
["Entity Address, City or Town","Redwood City,"," "]
["Entity Address, State or Province","CA"," "]
["Entity Address, Postal Zip Code","94063"," "]
["City Area Code","650"," "]
["Local Phone Number","503-2200"," "]
["Title of 12(b) Security","Class A Common Stock, par value $0.001 per share"," "]
["Trading Symbol","AI"," "]
["Security Exchange Name","NYSE"," "]
["Entity Current Reporting Status","Yes"," "]
["Entity Interactive Data Current","Yes"," "]
["Entity Filer Category","Large Accelerated Filer"," "]
["Entity Small Business","false"," "]
["Entity Emerging Growth Company","false"," "]
["Entity Shell Company","false"," "]
["Current Fiscal Year End Date","--04-30"," "]
["Amendment Flag","false"," "]
["Entity Central Index Key","0001577526"," "]
["Document Fiscal Year Focus","2025"," "]
["Document Fiscal Period Focus","Q3"," "]
["Class A Common Stock"," "," "]
["Document Information [Line Items]"," "," "]
["Entity Common Stock, Shares Outstanding (in shares)"," ",{"v":129238730,"d":"129,238,730 "}]
["Class B Common Stock"," "," "]
["Document Information [Line Items]"," "," "]
["Entity Common Stock, Shares Outstanding (in shares)"," ",{"v":3499992,"d":"3,499,992 "}]

{"sheet":"CONDENSED CONSOLIDATED BALANCE ","index":1,"n_rows":33,"n_cols":3,"rows_kept":33}
["CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024"]
["Current assets"," "," "]
["Cash and cash equivalents",{"v":125094,"d":"$ 125,094"},{"v":167146,"d":"$ 167,146"}]
["Marketable securities",{"v":599233,"d":"599,233 "},{"v":583221,"d":"583,221 "}]
["Accounts receivable, net of allowance of $642 and $359 as of January 31, 2025 and April 30, 2024, respectively",{"v":180357,"d":"180,357 "},{"v":130064,"d":"130,064 "}]
["Prepaid expenses and other current assets",{"v":26219,"d":"26,219 "},{"v":23963,"d":"23,963 "}]
["Total current assets",{"v":930903,"d":"930,903 "},{"v":904394,"d":"904,394 "}]
["Property and equipment, net",{"v":81910,"d":"81,910 "},{"v":88631,"d":"88,631 "}]
["Goodwill",{"v":625,"d":"625 "},{"v":625,"d":"625 "}]
["Other assets, non-current",{"v":41703,"d":"41,703 "},{"v":44575,"d":"44,575 "}]
["Total assets",{"v":1055141,"d":"1,055,141 "},{"v":1038225,"d":"1,038,225 "}]
["Current liabilities"," "," "]
["Accounts payable",{"v":28737,"d":"28,737 "},{"v":11316,"d":"11,316 "}]
["Accrued compensation and employee benefits",{"v":48727,"d":"48,727 "},{"v":44263,"d":"44,263 "}]
["Deferred revenue, current",{"v":32955,"d":"32,955 "},{"v":37230,"d":"37,230 "}]
["Accrued and other current liabilities",{"v":27628,"d":"27,628 "},{"v":9526,"d":"9,526 "}]
["Total current liabilities",{"v":138047,"d":"138,047 "},{"v":102335,"d":"102,335 "}]
["Deferred revenue, non-current",{"v":0,"d":"0 "},{"v":1732,"d":"1,732 "}]
["Other long-term liabilities",{"v":56917,"d":"56,917 "},{"v":60805,"d":"60,805 "}]
["Total liabilities",{"v":194964,"d":"194,964 "},{"v":164872,"d":"164,872 "}]
["Commitments and contingencies (note 6)"," "," "]
["Stockholders’ equity"," "," "]
["Additional paid-in capital",{"v":2158686,"d":"2,158,686 "},{"v":1963726,"d":"1,963,726 "}]
["Accumulated other comprehensive income (loss)",{"v":292,"d":"292 "},{"v":-563,"d":"(563)"}]
["Accumulated deficit",{"v":-1298933,"d":"(1,298,933)"},{"v":-1089933,"d":"(1,089,933)"}]
["Total stockholders’ equity",{"v":860177,"d":"860,177 "},{"v":873353,"d":"873,353 "}]
["Total liabilities and stockholders’ equity",{"v":1055141,"d":"1,055,141 "},{"v":1038225,"d":"1,038,225 "}]
["Class A Common Stock"," "," "]
["Stockholders’ equity"," "," "]
["Common stock",{"v":129,"d":"129 "},{"v":120,"d":"120 "}]
["Class B Common Stock"," "," "]
["Stockholders’ equity"," "," "]
["Common stock",{"v":3,"d":"$ 3"},{"v":3,"d":"$ 3"}]

{"sheet":"CONDENSED CONSOLIDATED BALANC_2","index":2,"n_rows":3,"n_cols":3,"rows_kept":3}
["CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024"]
["Statement of Financial Position [Abstract]"," "," "]
["Accounts receivable, allowance",{"v":642,"d":"$ 642"},{"v":359,"d":"$ 359"}]

{"sheet":"CONDENSED CONSOLIDATED STATEMEN","index":3,"n_rows":34,"n_cols":6,"rows_kept":34,"merged":[[0,0,1,1],[0,2,0,3],[0,4,0,5],[32,0,32,4],[33,0,33,4]]}
["CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands",null,"3 Months Ended",null,"9 Months Ended"]
[null,null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Revenue",null," "," "," "," "]
["Total revenue",null,{"v":98782,"d":"$ 98,782"},{"v":78401,"d":"$ 78,401"},{"v":280333,"d":"$ 280,333"},{"v":223992,"d":"$ 223,992"}]
["Cost of revenue",null," "," "," "," "]
["Total cost of revenue",null,{"v":40435,"d":"40,435 "},{"v":33114,"d":"33,114 "},{"v":111980,"d":"111,980 "},{"v":97043,"d":"97,043 "}]
["Gross profit",null,{"v":58347,"d":"58,347 "},{"v":45287,"d":"45,287 "},{"v":168353,"d":"168,353 "},{"v":126949,"d":"126,949 "}]
["Operating expenses",null," "," "," "," "]
["Sales and marketing","[1]",{"v":61201,"d":"61,201 "},{"v":57140,"d":"57,140 "},{"v":168969,"d":"168,969 "},{"v":150920,"d":"150,920 "}]
["Research and development",null,{"v":59356,"d":"59,356 "},{"v":49480,"d":"49,480 "},{"v":167998,"d":"167,998 "},{"v":150747,"d":"150,747 "}]
["General and administrative",null,{"v":25375,"d":"25,375 "},{"v":21213,"d":"21,213 "},{"v":66845,"d":"66,845 "},{"v":61317,"d":"61,317 "}]
["Total operating expenses",null,{"v":145932,"d":"145,932 "},{"v":127833,"d":"127,833 "},{"v":403812,"d":"403,812 "},{"v":362984,"d":"362,984 "}]
["Loss from operations",null,{"v":-87585,"d":"(87,585)"},{"v":-82546,"d":"(82,546)"},{"v":-235459,"d":"(235,459)"},{"v":-236035,"d":"(236,035)"}]
["Interest income",null,{"v":8677,"d":"8,677 "},{"v":9995,"d":"9,995 "},{"v":28240,"d":"28,240 "},{"v":30597,"d":"30,597 "}]
["Other (expense) income, net",null,{"v":-957,"d":"(957)"},{"v":409,"d":"409 "},{"v":-916,"d":"(916)"},{"v":-468,"d":"(468)"}]
["Loss before provision for income taxes",null,{"v":-79865,"d":"(79,865)"},{"v":-72142,"d":"(72,142)"},{"v":-208135,"d":"(208,135)"},{"v":-205906,"d":"(205,906)"}]
["Provision for income taxes",null,{"v":336,"d":"336 "},{"v":489,"d":"489 "},{"v":865,"d":"865 "},{"v":863,"d":"863 "}]
["Net loss",null,{"v":-80201,"d":"$ (80,201)"},{"v":-72631,"d":"$ (72,631)"},{"v":-209000,"d":"$ (209,000)"},{"v":-206769,"d":"$ (206,769)"}]
["Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)",null,{"v":-0.62,"d":"$ (0.62)"},{"v":-0.6,"d":"$ (0.60)"},{"v":-1.64,"d":"$ (1.64)"},{"v":-1.75,"d":"$ (1.75)"}]
["Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)",null,{"v":-0.62,"d":"$ (0.62)"},{"v":-0.6,"d":"$ (0.60)"},{"v":-1.64,"d":"$ (1.64)"},{"v":-1.75,"d":"$ (1.75)"}]
["Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)",null,{"v":130382,"d":"130,382 "},{"v":120486,"d":"120,486 "},{"v":127752,"d":"127,752 "},{"v":118259,"d":"118,259 "}]
["Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)",null,{"v":130382,"d":"130,382 "},{"v":120486,"d":"120,486 "},{"v":127752,"d":"127,752 "},{"v":118259,"d":"118,259 "}]
["Subscription",null," "," "," "," "]
["Revenue",null," "," "," "," "]
["Total revenue","[2]",{"v":85679,"d":"$ 85,679"},{"v":70400,"d":"$ 70,400"},{"v":240297,"d":"$ 240,297"},{"v":198201,"d":"$ 198,201"}]
["Cost of revenue",null," "," "," "," "]
["Total cost of revenue",null,{"v":37799,"d":"37,799 "},{"v":32273,"d":"32,273 "},{"v":106129,"d":"106,129 "},{"v":93644,"d":"93,644 "}]
["Professional services",null," "," "," "," "]
["Revenue",null," "," "," "," "]
["Total revenue","[3]",{"v":13103,"d":"13,103 "},{"v":8001,"d":"8,001 "},{"v":40036,"d":"40,036 "},{"v":25791,"d":"25,791 "}]
["Cost of revenue",null," "," "," "," "]
["Total cost of revenue",null,{"v":2636,"d":"$ 2,636"},{"v":841,"d":"$ 841"},{"v":5851,"d":"$ 5,851"},{"v":3399,"d":"$ 3,399"}]
[]
["[1]Including related party sales and marketing expense of $810 for the nine months ended January 31, 2024.[2]Including related party revenue of $10,581 for the nine months ended January 31, 2024.[3]Including related party revenue of $5,804 for the nine months ended January 31, 2024."]

{"sheet":"CONDENSED CONSOLIDATED STATEM_2","index":4,"n_rows":16,"n_cols":6,"rows_kept":16,"merged":[[0,0,1,1],[0,2,0,3],[0,4,0,5],[14,0,14,4],[15,0,15,4]]}
["CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands",null,"3 Months Ended",null,"9 Months Ended"]
[null,null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Related party revenue",null,{"v":98782,"d":"$ 98,782"},{"v":78401,"d":"$ 78,401"},{"v":280333,"d":"$ 280,333"},{"v":223992,"d":"$ 223,992"}]
["Related party sales and marketing","[1]",{"v":61201,"d":"61,201 "},{"v":57140,"d":"57,140 "},{"v":168969,"d":"168,969 "},{"v":150920,"d":"150,920 "}]
["Related Party",null," "," "," "," "]
["Related party sales and marketing",null," "," "," ",{"v":810,"d":"810 "}]
["Subscription",null," "," "," "," "]
["Related party revenue","[2]",{"v":85679,"d":"85,679 "},{"v":70400,"d":"70,400 "},{"v":240297,"d":"240,297 "},{"v":198201,"d":"198,201 "}]
["Subscription | Related Party",null," "," "," "," "]
["Related party revenue",null," "," "," ",{"v":10581,"d":"10,581 "}]
["Professional services",null," "," "," "," "]
["Related party revenue","[3]",{"v":13103,"d":"$ 13,103"},{"v":8001,"d":"$ 8,001"},{"v":40036,"d":"$ 40,036"},{"v":25791,"d":"25,791 "}]
["Professional services | Related Party",null," "," "," "," "]
["Related party revenue",null," "," "," ",{"v":5804,"d":"$ 5,804"}]
[]
["[1]Including related party sales and marketing expense of $810 for the nine months ended January 31, 2024.[2]Including related party revenue of $10,581 for the nine months ended January 31, 2024.[3]Including related party revenue of $5,804 for the nine months ended January 31, 2024."]

{"sheet":"CONDENSED CONSOLIDATED STATEM_3","index":5,"n_rows":7,"n_cols":5,"rows_kept":7,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Statement of Comprehensive Income [Abstract]"," "," "," "," "]
["Net loss",{"v":-80201,"d":"$ (80,201)"},{"v":-72631,"d":"$ (72,631)"},{"v":-209000,"d":"$ (209,000)"},{"v":-206769,"d":"$ (206,769)"}]
["Other comprehensive (loss) income"," "," "," "," "]
["Unrealized (loss) gain on available-for-sale marketable securities, net of tax",{"v":-229,"d":"(229)"},{"v":1205,"d":"1,205 "},{"v":855,"d":"855 "},{"v":815,"d":"815 "}]
["Comprehensive loss",{"v":-80430,"d":"$ (80,430)"},{"v":-71426,"d":"$ (71,426)"},{"v":-208145,"d":"$ (208,145)"},{"v":-205954,"d":"$ (205,954)"}]

{"sheet":"CONDENSED CONSOLIDATED STATEM_4","index":6,"n_rows":65,"n_cols":9,"rows_kept":65}
["CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands","Total","RSUs","Common Stock","Common Stock RSUs","Additional Paid-In Capital","Additional Paid-In Capital RSUs","Accumulated Other Comprehensive Income (Loss)","Accumulated Deficit"]
["Beginning Balance, shares (in shares) at Apr. 30, 2023"," "," ",{"v":113943,"d":"113,943 "}," "," "," "," "," "]
["Beginning Balance, Amount at Apr. 30, 2023",{"v":929665,"d":"$ 929,665"}," ",{"v":113,"d":"$ 113"}," ",{"v":1740174,"d":"$ 1,740,174"}," ",{"v":-385,"d":"$ (385)"},{"v":-810237,"d":"$ (810,237)"}]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "," "," "]
["Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)"," "," ",{"v":2534,"d":"2,534 "}," "," "," "," "," "]
["Issuance of Class A common stock upon exercise of stock options, net of repurchases",{"v":11319,"d":"11,319 "}," ",{"v":2,"d":"$ 2"}," ",{"v":11317,"d":"11,317 "}," "," "," "]
["Vesting of early exercised Class A common stock options",{"v":406,"d":"406 "}," "," "," ",{"v":406,"d":"406 "}," "," "," "]
["Shares withheld related to net share settlement of equity awards (in shares)"," "," ",{"v":-283,"d":"(283)"}," "," "," "," "," "]
["Shares withheld related to net share settlement of equity awards",{"v":-10485,"d":"(10,485)"}," "," "," ",{"v":-10485,"d":"(10,485)"}," "," "," "]
["Vesting of restricted stock units (in shares)"," "," "," ",{"v":5004,"d":"5,004 "}," "," "," "," "]
["Vesting of restricted stock units"," ",{"v":34475,"d":"$ 34,475"}," ",{"v":5,"d":"$ 5"}," ",{"v":34470,"d":"$ 34,470"}," "," "]
["Issuance of Class A common stock under employee stock purchase plan (in shares)"," "," ",{"v":429,"d":"429 "}," "," "," "," "," "]
["Issuance of Class A common stock under employee stock purchase plan",{"v":5055,"d":"5,055 "}," ",{"v":1,"d":"$ 1"}," ",{"v":5054,"d":"5,054 "}," "," "," "]
["Stock-based compensation expense",{"v":133514,"d":"133,514 "}," "," "," ",{"v":133514,"d":"133,514 "}," "," "," "]
["Other comprehensive income",{"v":815,"d":"815 "}," "," "," "," "," ",{"v":815,"d":"815 "}," "]
["Net loss",{"v":-206769,"d":"(206,769)"}," "," "," "," "," "," ",{"v":-206769,"d":"(206,769)"}]
["Ending Balance, shares (in shares) at Jan. 31, 2024"," "," ",{"v":121627,"d":"121,627 "}," "," "," "," "," "]
["Ending Balance, Amount at Jan. 31, 2024",{"v":897995,"d":"897,995 "}," ",{"v":121,"d":"$ 121"}," ",{"v":1914450,"d":"1,914,450 "}," ",{"v":430,"d":"430 "},{"v":-1017006,"d":"(1,017,006)"}]
["Beginning Balance, shares (in shares) at Oct. 31, 2023"," "," ",{"v":119653,"d":"119,653 "}," "," "," "," "," "]
["Beginning Balance, Amount at Oct. 31, 2023",{"v":911276,"d":"911,276 "}," ",{"v":119,"d":"$ 119"}," ",{"v":1856307,"d":"1,856,307 "}," ",{"v":-775,"d":"(775)"},{"v":-944375,"d":"(944,375)"}]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "," "," "]
["Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)"," "," ",{"v":283,"d":"283 "}," "," "," "," "," "]
["Issuance of Class A common stock upon exercise of stock options, net of repurchases",{"v":1209,"d":"1,209 "}," "," "," ",{"v":1209,"d":"1,209 "}," "," "," "]
["Vesting of early exercised Class A common stock options",{"v":112,"d":"112 "}," "," "," ",{"v":112,"d":"112 "}," "," "," "]
["Shares withheld related to net share settlement of equity awards (in shares)"," "," ",{"v":-30,"d":"(30)"}," "," "," "," "," "]
["Shares withheld related to net share settlement of equity awards",{"v":-720,"d":"(720)"}," "," "," ",{"v":-720,"d":"(720)"}," "," "," "]
["Vesting of restricted stock units (in shares)"," "," "," ",{"v":1721,"d":"1,721 "}," "," "," "," "]
["Vesting of restricted stock units"," ",{"v":13006,"d":"13,006 "}," ",{"v":2,"d":"$ 2"}," ",{"v":13004,"d":"13,004 "}," "," "]
["Stock-based compensation expense",{"v":44538,"d":"44,538 "}," "," "," ",{"v":44538,"d":"44,538 "}," "," "," "]
["Other comprehensive income",{"v":1205,"d":"1,205 "}," "," "," "," "," ",{"v":1205,"d":"1,205 "}," "]
["Net loss",{"v":-72631,"d":"(72,631)"}," "," "," "," "," "," ",{"v":-72631,"d":"(72,631)"}]
["Ending Balance, shares (in shares) at Jan. 31, 2024"," "," ",{"v":121627,"d":"121,627 "}," "," "," "," "," "]
["Ending Balance, Amount at Jan. 31, 2024",{"v":897995,"d":"897,995 "}," ",{"v":121,"d":"$ 121"}," ",{"v":1914450,"d":"1,914,450 "}," ",{"v":430,"d":"430 "},{"v":-1017006,"d":"(1,017,006)"}]
["Beginning Balance, shares (in shares) at Apr. 30, 2024"," "," ",{"v":123706,"d":"123,706 "}," "," "," "," "," "]
["Beginning Balance, Amount at Apr. 30, 2024",{"v":873353,"d":"$ 873,353"}," ",{"v":123,"d":"$ 123"}," ",{"v":1963726,"d":"1,963,726 "}," ",{"v":-563,"d":"(563)"},{"v":-1089933,"d":"(1,089,933)"}]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "," "," "]
["Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)",{"v":3169,"d":"3,169 "}," ",{"v":3171,"d":"3,171 "}," "," "," "," "," "]
["Issuance of Class A common stock upon exercise of stock options, net of repurchases",{"v":19642,"d":"$ 19,642"}," ",{"v":3,"d":"$ 3"}," ",{"v":19639,"d":"19,639 "}," "," "," "]
["Vesting of early exercised Class A common stock options",{"v":251,"d":"251 "}," "," "," ",{"v":251,"d":"251 "}," "," "," "]
["Shares withheld related to net share settlement of equity awards (in shares)"," "," ",{"v":-281,"d":"(281)"}," "," "," "," "," "]
["Shares withheld related to net share settlement of equity awards",{"v":-7496,"d":"(7,496)"}," "," "," ",{"v":-7496,"d":"(7,496)"}," "," "," "]
["Vesting of restricted stock units (in shares)"," "," "," ",{"v":5381,"d":"5,381 "}," "," "," "," "]
["Vesting of restricted stock units"," ",{"v":40745,"d":"40,745 "}," ",{"v":6,"d":"$ 6"}," ",{"v":40739,"d":"40,739 "}," "," "]
["Issuance of Class A common stock under employee stock purchase plan (in shares)"," "," ",{"v":378,"d":"378 "}," "," "," "," "," "]
["Issuance of Class A common stock under employee stock purchase plan",{"v":5009,"d":"5,009 "}," "," "," ",{"v":5009,"d":"5,009 "}," "," "," "]
["Stock-based compensation expense",{"v":136818,"d":"136,818 "}," "," "," ",{"v":136818,"d":"136,818 "}," "," "," "]
["Other comprehensive income",{"v":855,"d":"855 "}," "," "," "," "," ",{"v":855,"d":"855 "}," "]
["Net loss",{"v":-209000,"d":"(209,000)"}," "," "," "," "," "," ",{"v":-209000,"d":"(209,000)"}]
["Ending Balance, shares (in shares) at Jan. 31, 2025"," "," ",{"v":132355,"d":"132,355 "}," "," "," "," "," "]
["Ending Balance, Amount at Jan. 31, 2025",{"v":860177,"d":"860,177 "}," ",{"v":132,"d":"$ 132"}," ",{"v":2158686,"d":"2,158,686 "}," ",{"v":292,"d":"292 "},{"v":-1298933,"d":"(1,298,933)"}]
["Beginning Balance, shares (in shares) at Oct. 31, 2024"," "," ",{"v":128781,"d":"128,781 "}," "," "," "," "," "]
["Beginning Balance, Amount at Oct. 31, 2024",{"v":858961,"d":"858,961 "}," ",{"v":128,"d":"$ 128"}," ",{"v":2077044,"d":"2,077,044 "}," ",{"v":521,"d":"521 "},{"v":-1218732,"d":"(1,218,732)"}]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "," "," "]
["Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)"," "," ",{"v":2107,"d":"2,107 "}," "," "," "," "," "]
["Issuance of Class A common stock upon exercise of stock options, net of repurchases",{"v":15175,"d":"15,175 "}," ",{"v":2,"d":"$ 2"}," ",{"v":15173,"d":"15,173 "}," "," "," "]
["Vesting of early exercised Class A common stock options",{"v":35,"d":"35 "}," "," "," ",{"v":35,"d":"35 "}," "," "," "]
["Shares withheld related to net share settlement of equity awards (in shares)"," "," ",{"v":-56,"d":"(56)"}," "," "," "," "," "]
["Shares withheld related to net share settlement of equity awards",{"v":-1709,"d":"(1,709)"}," "," "," ",{"v":-1709,"d":"(1,709)"}," "," "," "]
["Vesting of restricted stock units (in shares)"," "," "," ",{"v":1523,"d":"1,523 "}," "," "," "," "]
["Vesting of restricted stock units"," ",{"v":17212,"d":"$ 17,212"}," ",{"v":2,"d":"$ 2"}," ",{"v":17210,"d":"$ 17,210"}," "," "]
["Stock-based compensation expense",{"v":50933,"d":"50,933 "}," "," "," ",{"v":50933,"d":"50,933 "}," "," "," "]
["Other comprehensive income",{"v":-229,"d":"(229)"}," "," "," "," "," ",{"v":-229,"d":"(229)"}," "]
["Net loss",{"v":-80201,"d":"(80,201)"}," "," "," "," "," "," ",{"v":-80201,"d":"(80,201)"}]
["Ending Balance, shares (in shares) at Jan. 31, 2025"," "," ",{"v":132355,"d":"132,355 "}," "," "," "," "," "]
["Ending Balance, Amount at Jan. 31, 2025",{"v":860177,"d":"$ 860,177"}," ",{"v":132,"d":"$ 132"}," ",{"v":2158686,"d":"$ 2,158,686"}," ",{"v":292,"d":"$ 292"},{"v":-1298933,"d":"$ (1,298,933)"}]

{"sheet":"CONDENSED CONSOLIDATED STATEM_5","index":7,"n_rows":47,"n_cols":6,"rows_kept":47,"merged":[[0,0,1,1],[0,2,0,3],[0,4,0,5],[45,0,45,4],[46,0,46,4]]}
["CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands",null,"3 Months Ended",null,"9 Months Ended"]
[null,null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Cash flows from operating activities:",null," "," "," "," "]
["Net loss",null,{"v":-80201,"d":"$ (80,201)"},{"v":-72631,"d":"$ (72,631)"},{"v":-209000,"d":"$ (209,000)"},{"v":-206769,"d":"$ (206,769)"}]
["Adjustments to reconcile net loss to net cash used in operating activities",null," "," "," "," "]
["Depreciation and amortization",null," "," ",{"v":9215,"d":"9,215 "},{"v":9469,"d":"9,469 "}]
["Non-cash operating lease cost",null," "," ",{"v":270,"d":"270 "},{"v":656,"d":"656 "}]
["Stock-based compensation expense",null," "," ",{"v":174373,"d":"174,373 "},{"v":159032,"d":"159,032 "}]
["Accretion of discounts on marketable securities",null," "," ",{"v":-10715,"d":"(10,715)"},{"v":-13238,"d":"(13,238)"}]
["Other",null," "," ",{"v":2158,"d":"2,158 "},{"v":110,"d":"110 "}]
["Changes in operating assets and liabilities",null," "," "," "," "]
["Accounts receivable","[1]"," "," ",{"v":-52017,"d":"(52,017)"},{"v":-38892,"d":"(38,892)"}]
["Prepaid expenses, other current assets and other assets","[2]"," "," ",{"v":587,"d":"587 "},{"v":-3379,"d":"(3,379)"}]
["Accounts payable","[3]"," "," ",{"v":16916,"d":"16,916 "},{"v":-4945,"d":"(4,945)"}]
["Accrued compensation and employee benefits",null," "," ",{"v":7648,"d":"7,648 "},{"v":171,"d":"171 "}]
["Operating lease liabilities",null," "," ",{"v":1439,"d":"1,439 "},{"v":14330,"d":"14,330 "}]
["Other liabilities","[4]"," "," ",{"v":12462,"d":"12,462 "},{"v":6296,"d":"6,296 "}]
["Deferred revenue","[5]"," "," ",{"v":-6007,"d":"(6,007)"},{"v":-6546,"d":"(6,546)"}]
["Net cash used in operating activities",null," "," ",{"v":-52671,"d":"(52,671)"},{"v":-83705,"d":"(83,705)"}]
["Cash flows from investing activities:",null," "," "," "," "]
["Purchases of property and equipment",null," "," ",{"v":-2101,"d":"(2,101)"},{"v":-22718,"d":"(22,718)"}]
["Capitalized software development costs",null," "," ",{"v":0,"d":"0 "},{"v":-2750,"d":"(2,750)"}]
["Purchases of marketable securities",null," "," ",{"v":-518806,"d":"(518,806)"},{"v":-657431,"d":"(657,431)"}]
["Maturities and sales of marketable securities",null," "," ",{"v":514365,"d":"514,365 "},{"v":590299,"d":"590,299 "}]
["Net cash used in investing activities",null," "," ",{"v":-6542,"d":"(6,542)"},{"v":-92600,"d":"(92,600)"}]
["Cash flows from financing activities:",null," "," "," "," "]
["Proceeds from issuance of Class A common stock under employee stock purchase plan",null," "," ",{"v":5009,"d":"5,009 "},{"v":5055,"d":"5,055 "}]
["Proceeds from exercise of Class A common stock options",null," "," ",{"v":19648,"d":"19,648 "},{"v":11379,"d":"11,379 "}]
["Taxes paid related to net share settlement of equity awards",null," "," ",{"v":-7496,"d":"(7,496)"},{"v":-10397,"d":"(10,397)"}]
["Net cash provided by financing activities",null," "," ",{"v":17161,"d":"17,161 "},{"v":6037,"d":"6,037 "}]
["Net decrease in cash, cash equivalents and restricted cash",null," "," ",{"v":-42052,"d":"(42,052)"},{"v":-170268,"d":"(170,268)"}]
["Cash, cash equivalents and restricted cash at beginning of period",null," "," ",{"v":179712,"d":"179,712 "},{"v":297395,"d":"297,395 "}]
["Cash and cash equivalents",null,{"v":125094,"d":"125,094 "},{"v":114561,"d":"114,561 "},{"v":125094,"d":"125,094 "},{"v":114561,"d":"114,561 "}]
["Restricted cash included in other assets, non-current",null,{"v":12566,"d":"12,566 "},{"v":12566,"d":"12,566 "},{"v":12566,"d":"12,566 "},{"v":12566,"d":"12,566 "}]
["Cash, cash equivalents and restricted cash at end of period",null,{"v":137660,"d":"137,660 "},{"v":127127,"d":"127,127 "},{"v":137660,"d":"137,660 "},{"v":127127,"d":"127,127 "}]
["Cash and cash equivalents",null,{"v":125094,"d":"125,094 "},{"v":114561,"d":"114,561 "},{"v":125094,"d":"125,094 "},{"v":114561,"d":"114,561 "}]
["Restricted cash included in other assets, non-current",null,{"v":12566,"d":"12,566 "},{"v":12566,"d":"12,566 "},{"v":12566,"d":"12,566 "},{"v":12566,"d":"12,566 "}]
["Total cash, cash equivalents and restricted cash",null,{"v":137660,"d":"137,660 "},{"v":127127,"d":"127,127 "},{"v":137660,"d":"137,660 "},{"v":127127,"d":"127,127 "}]
["Cash and cash equivalents",null,{"v":125094,"d":"125,094 "},{"v":114561,"d":"114,561 "},{"v":125094,"d":"125,094 "},{"v":114561,"d":"114,561 "}]
["Restricted cash included in other assets, non-current",null,{"v":12566,"d":"$ 12,566"},{"v":12566,"d":"$ 12,566"},{"v":12566,"d":"12,566 "},{"v":12566,"d":"12,566 "}]
["Supplemental disclosure of cash flow information—cash paid for income taxes",null," "," ",{"v":743,"d":"743 "},{"v":760,"d":"760 "}]
["Supplemental disclosures of non-cash investing and financing activities:",null," "," "," "," "]
["Purchases of property and equipment included in accounts payable and accrued liabilities",null," "," ",{"v":527,"d":"527 "},{"v":2475,"d":"2,475 "}]
["Right-of-use assets obtained in exchange for lease obligations (including remeasurement of right-of-use assets and lease liabilities due to changes in the timing of receipt of lease incentives)",null," "," ",{"v":1016,"d":"1,016 "},{"v":1858,"d":"1,858 "}]
["Vesting of early exercised stock options",null," "," ",{"v":251,"d":"$ 251"},{"v":406,"d":"$ 406"}]
[]
["[1] Including changes in related party balances of $12,444 for the nine months ended January 31, 2024. Including changes in related party balances of $(810) for the nine months ended January 31, 2024. Including changes in related party balances of $248 for the nine months ended January 31, 2024. Including changes in related party balances of $(2,448) for the nine months ended January 31, 2024. Including changes in related party balances of $(46) for the nine months ended January 31, 2024."]

{"sheet":"CONDENSED CONSOLIDATED STATEM_6","index":8,"n_rows":12,"n_cols":3,"rows_kept":12,"merged":[[0,0,1,0],[0,1,0,2],[1,1,1,2],[10,0,10,2],[11,0,11,2]]}
["CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Thousands","9 Months Ended"]
[null,"Jan. 31, 2024 USD ($)"]
["Related party balanced included in prepaid expenses, other current assets and other assets",{"v":3379,"d":"$ 3,379"},"[1]"]
["Related party balances included in other liabilities",{"v":6296,"d":"6,296 "},"[2]"]
["Related Party"," "]
["Related party balances included in accounts receivable",{"v":12444,"d":"12,444 "}]
["Related party balanced included in prepaid expenses, other current assets and other assets",{"v":-810,"d":"(810)"}]
["Related party balances included in accounts payable",{"v":248,"d":"248 "}]
["Related party balances included in other liabilities",{"v":-2448,"d":"(2,448)"}]
["Related party balance included in deferred revenue",{"v":-46,"d":"$ (46)"}]
[]
["[1] Including changes in related party balances of $(810) for the nine months ended January 31, 2024. Including changes in related party balances of $(2,448) for the nine months ended January 31, 2024."]

{"sheet":"Summary of Business and Signifi","index":9,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Summary of Business and Significant Accounting Policies","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Summary of Business and Significant Accounting Policies","Summary of Business and Significant Accounting Policies Business C3.ai, Inc. (including its subsidiaries, “C3 AI” or “the Company”) is an enterprise artificial intelligence (“AI”) software provider. The Company delivers a family of fully integrated products including the C3 AI Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications, C3 AI applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally, and C3 Generative AI, a suite of domain-specific generative AI offerings for the enterprise. The Company supports customers in the United States, Europe, and other parts of the world. The Company was initially formed as a limited liability company in Delaware on January 8, 2009 and converted to a Delaware corporation in June 2012. Basis of Presentation and Principles of Consolidation The Company prepares its unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2024, which was filed with the SEC on June 18, 2024. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of January 31, 2025 and the results of operations for the three and nine months ended January 31, 2025, and cash flows for the nine months ended January 31, 2025. The results of operations for the three and nine months ended January 31, 2025 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Such estimates include, but are not limited to, determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases, other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Fiscal Year The Company’s fiscal year ends on April 30. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 1. Summary of Business and Significant Accounting Policies in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the fiscal year ended April 30, 2024, which was filed with the SEC on June 18, 2024. There have been no significant changes to these policies during the three and nine months ended January 31, 2025. Recently Issued Accounting Standards Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to improve the disclosures regarding a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The Company is required to adopt the guidance in the fourth quarter of fiscal 2025, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures (“ASU 2023-09”) to provide disaggregated income tax disclosures on rate reconciliation and income taxes paid. The Company is required to adopt the guidance in the fourth quarter of fiscal 2026, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements. In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income (Topic 220) Disaggregation of Income Statement Expenses (“ASU 2024-03”), to enhance the transparency and decision usefulness of financial information presented in the income statement by requiring disaggregated information about certain income statement expense line items. The Company is required to adopt the guidance in the fourth quarter of fiscal 2028, though early adoption permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements."]

{"sheet":"Revenue","index":10,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Revenue","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Revenue from Contract with Customer [Abstract]"," "]
["Revenue","Revenue Disaggregation of Revenue The following table presents revenue by geographical region (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2025 2024 2025 2024 North America (1) $ 87,289 $ 68,356 $ 248,838 $ 191,247 Europe, the Middle East and Africa (1) 11,085 9,040 29,978 29,205 Asia Pacific (1) 13 952 274 2,877 Rest of World (1) 395 53 1,243 663 Total revenue $ 98,782 $ 78,401 $ 280,333 $ 223,992 __________________ (1) The United States comprised 86% and 86% of the Company’s revenue for the three months ended January 31, 2025 and 2024, respectively, and 87% and 85% of the Company’s revenue for the nine months ended January 31, 2025 and 2024, respectively. No other country comprised 10% or greater of the Company’s revenue for the three and nine months ended January 31, 2025 or 2024. Revenue is recognized at the time the related performance obligation is satisfied with the transfer of a promised good or service to a customer over time. For the significant majority of the Company’s offerings, software and maintenance and support services are highly interdependent and interrelated and represent a single performance obligation within the context of the contract and are generally satisfied over time. Revenue from software licenses that do not require maintenance and support services is recognized when the control of the software is transferred to the customer. Revenue from such software licenses was $28.6 million and $8.4 million during the three months ended January 31, 2025 and 2024, respectively, and $60.4 million and $15.4 million during the nine months ended January 31, 2025 and 2024, respectively. Professional Services revenue primarily include service fees and prioritized engineering services. Service fees include revenue from services such as consulting, training, and paid implementation services. For service fees, revenue is typically recognized over time as the services are performed. Prioritized engineering services are undertaken when a customer requests that the Company accelerate the design, development, and delivery of software features and functions that are planned in future product roadmap. When the Company agrees to this, an agreed upon fee is negotiated to accelerate the development of the software as well as other terms, such as relevant specifications. When the software feature is delivered, it becomes integrated to the Company’s core product offering, is available to all subscribers of the underlying software product and enhances the operation of that product going forward. Such prioritized engineering services result in production-level computer software – compiled code that enhances the functionality of our production products – which is available for customers to use over the life of their software licenses. Prioritized engineering services revenue is recognized as professional services over the period in which the software development is completed. Total professional services revenue comprised of (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2025 2024 2025 2024 Prioritized engineering services $ 5,698 $ 7,125 $ 26,008 $ 20,225 Service fees 7,405 876 14,028 5,566 Total professional services revenue $ 13,103 $ 8,001 $ 40,036 $ 25,791 Deferred Revenue As of January 31, 2025 and April 30, 2024, the Company’s deferred revenue balances were $33.0 million and $39.0 million, respectively. Revenue of $37.8 million and $46.3 million was recognized during the nine months ended January 31, 2025 and 2024, respectively, that was included in the deferred revenue balances as of April 30, 2024 and 2023, respectively. Remaining Performance Obligation Remaining performance obligations are committed and represent non-cancellable contracted revenue that has not yet been recognized and will be recognized as revenue in future periods. Some contracts allow customers to cancel the contracts without a significant penalty, and the cancellable amount of contract value is not included in the remaining performance obligations. The Company excludes amounts related to performance obligations and usage-based royalties that are billed and recognized as they are delivered or billed and recognized in the same period. This primarily consists of monthly usage-based runtime and hosting charges in the duration of some revenue contracts. Revenue expected to be recognized from remaining performance obligations was approximately $208.2 million as of January 31, 2025, which includes $74.6 million of non-cancellable commitments where actual product selection and quantities of specific products or services will be determined at a later date. Approximately $124.0 million is expected to be recognized over the next 12 months and a majority of the remaining amount is expected to be recognized over the next 13 to 48 months. Customer Concentration and Accounts Receivable A majority of the Company’s Customer-Entities consist of corporate and governmental entities. A Customer-Entity is defined as each entity that is the ultimate parent of a party contracting with the Company. A limited number of Customer-Entities have accounted for a large part of the Company’s revenue and accounts receivable to date. For the purpose of determining customer concentration and accounts receivable, unbilled receivables have been excluded from the accounts receivable balance. Two separate Customer-Entities accounted for 15% and 10%, respectively, of revenue for the three months ended January 31, 2025. Two separate Customer-Entities accounted for 25% and 12%, respectively, of revenue for the three months ended January 31, 2024. One Customer-Entity accounted for 18% of revenue for the nine months ended January 31, 2025. Two separate Customer-Entities accounted for 27% and 13%, respectively, of revenue for the nine months ended January 31, 2024. Four Customer-Entities accounted for 14%, 14%, 13% and 11%, respectively, of accounts receivable at January 31, 2025. Two separate Customer-Entities accounted for 25% and 16%, respectively, of accounts receivable at April 30, 2024. Accounts receivable includes billed and unbilled receivables, net of allowance of doubtful accounts. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The allowance for credit losses is based on the Company’s assessment of the collectability of accounts receivable by considering various factors, including the age of each outstanding invoice, customer type, the collection history of each customer, historical write-off experience, current and near-term macroeconomic conditions and uncertainties. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. Accounts receivable included unbilled receivables as of January 31, 2025 and April 30, 2024 of $89.8 million and $62.3 million, respectively."]

{"sheet":"Fair Value Measurements","index":11,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Fair Value Measurements","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Fair Value Disclosures [Abstract]"," "]
["Fair Value Measurements","Fair Value Measurements The Company’s financial instruments consist primarily of cash equivalents, restricted cash, available-for-sale marketable securities, accounts receivable, and accounts payable. Cash equivalents and available-for-sale marketable securities are reported at their respective fair values on the condensed consolidated balance sheets. The remaining financial instruments are reported on the condensed consolidated balance sheets at amounts that approximate current fair values. The following table summarizes the types of assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): As of January 31, 2025 As of April 30, 2024 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 77,902 $ — $ — $ 77,902 $ 82,564 $ — $ — $ 82,564 Commercial paper — 6,971 — 6,971 — 18,769 — 18,769 U.S. treasury securities — — — — — 5,888 — 5,888 Certificates of deposit — 3,960 — 3,960 — — — — Available-for-sale marketable securities: U.S. treasury securities — 14,395 — 14,395 — 2,497 — 2,497 Certificates of deposit — 84,645 — 84,645 — 62,017 — 62,017 U.S. government agencies securities — 60,457 — 60,457 — 46,428 — 46,428 Commercial paper — 108,045 — 108,045 — 162,183 — 162,183 Corporate debt securities — 331,691 — 331,691 — 310,095 — 310,095 Total cash equivalents and available-for-sale marketable securities $ 77,902 $ 610,164 $ — $ 688,066 $ 82,564 $ 607,877 $ — $ 690,441 The estimated fair value of securities classified as Level 2 financial instruments was determined based on third-party pricing services. The pricing services utilize industry standard valuation models, including both income- and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. Inputs used for fair value measurement categorized as Level 2 include benchmark yields, reported trades, broker or dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications."]

{"sheet":"Cash Equivalents and Marketable","index":12,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Cash Equivalents and Marketable Securities","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Investments, Debt and Equity Securities [Abstract]"," "]
["Cash Equivalents and Marketable Securities","Cash Equivalents and Marketable Securities The following table summarizes the Company’s cash equivalents and available-for-sale marketable securities (in thousands): As of January 31, 2025 As of April 30, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 77,902 $ — $ — $ 77,902 $ 82,564 $ — $ — $ 82,564 Commercial paper 6,971 — — 6,971 18,769 — — 18,769 U.S. treasury securities — — — — 5,888 — — 5,888 Certificates of deposit 3,960 — — 3,960 — — — — Available-for-sale marketable securities: U.S. treasury securities 14,382 13 — 14,395 2,497 — — 2,497 Certificates of deposit 84,645 — — 84,645 62,017 — — 62,017 U.S. government agencies securities 60,536 76 (155) 60,457 46,527 5 (104) 46,428 Commercial paper 108,045 — — 108,045 162,183 — — 162,183 Corporate debt securities 331,331 679 (319) 331,691 310,557 64 (526) 310,095 Total cash equivalents and available-for-sale marketable securities $ 687,772 $ 768 $ (474) $ 688,066 $ 691,002 $ 69 $ (630) $ 690,441 The following table summarizes the Company’s available-for-sale marketable securities by contractual maturity (in thousands): As of January 31, 2025 As of April 30, 2024 Amortized Cost Fair Value Amortized Cost Fair Value Within one year $ 494,233 $ 494,937 $ 514,747 $ 514,484 After one year through five years 104,706 104,296 69,034 68,736 Total $ 598,939 $ 599,233 $ 583,781 $ 583,220 The following table summarizes the fair values and unrealized losses of the Company’s available-for-sale marketable securities classified by length of time that the securities have been in a continuous unrealized loss position but were not deemed to be other-than-temporarily impaired (in thousands): As of January 31, 2025 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. government agencies securities $ (155) $ 18,817 $ — $ — $ (155) $ 18,817 Commercial paper — 3,517 — — — 3,517 Corporate debt securities (319) 37,727 — — (319) 37,727 Total $ (474) $ 60,061 $ — $ — $ (474) $ 60,061 As of April 30, 2024 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. treasury securities $ — $ 2,497 $ — $ — $ — $ 2,497 U.S. government agencies securities (99) 33,890 (6) 7,749 (105) 41,639 Commercial paper — 4,058 — — — 4,058 Corporate debt securities (491) 196,907 (34) 27,658 (525) 224,565 Total $ (590) $ 237,352 $ (40) $ 35,407 $ (630) $ 272,759 "]

{"sheet":"Balance Sheet Details","index":13,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Balance Sheet Details","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Balance Sheet Details","Balance Sheet Details Property and Equipment, Net Property and equipment consisted of the following at January 31, 2025 and April 30, 2024 (in thousands): Useful Life As of January 31, As of April 30, (in months) 2025 2024 Leasehold improvements * $ 82,507 $ 71,867 Computer equipment 36 6,702 4,936 Office furniture and equipment 60 15,517 14,479 Capital work-in-progress NA 811 12,122 Property and equipment, gross 105,537 103,404 Less: accumulated depreciation and amortization (23,627) (14,773) Property and equipment, net $ 81,910 $ 88,631 __________________ * Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. NA = Not Applicable Capital work-in-progress primarily consisted of costs related to various leasehold improvements in connection with leased space that is not considered available for use and has not yet been placed into service. Depreciation and amortization expense related to property and equipment was $3.1 million and $2.9 million for the three months ended January 31, 2025 and 2024, respectively, and $8.9 million and $8.5 million for the nine months ended January 31, 2025 and 2024, respectively. Accrued Compensation and Employee Benefits Accrued compensation and employee benefits consisted of the following at January 31, 2025 and April 30, 2024 (in thousands): As of January 31, As of April 30, 2025 2024 Accrued bonus $ 32,875 $ 31,530 Accrued vacation 3,918 4,317 Accrued payroll taxes and benefits 1,959 3,636 Accrued commissions 5,116 2,826 ESPP contributions 4,596 1,409 Other 263 545 Accrued compensation and employee benefits $ 48,727 $ 44,263 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following at January 31, 2025 and April 30, 2024 (in thousands): As of January 31, As of April 30, 2025 2024 Accrued general expenses 3,678 2,783 Operating lease liabilities, current 4,490 3,226 Accrued professional services 7,008 2,082 Accrued cloud hosting services 6,687 643 Accrued taxes payable 2,744 621 Other 3,021 171 Accrued and other current liabilities $ 27,628 $ 9,526 "]

{"sheet":"Commitments and Contingencies","index":14,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Commitments and Contingencies","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Commitments and Contingencies Disclosure [Abstract]"," "]
["Commitments and Contingencies","Commitments and Contingencies Non-cancellable Purchase Commitments In the normal course of business, the Company enters into non-cancellable purchase commitments with various parties. As of January 31, 2025, the Company had remaining purchase commitments of $438.1 million related to cloud hosting and associated services and $93.2 million related to professional services due over the next one C3.ai Digital Transformation Institute Grants In February 2020, the Company entered into an agreement establishing the C3.ai Digital Transformation Institute (“C3.ai DTI”), a program established to attract many of the world’s leading research institutions to join in a coordinated and innovative effort to advance the digital transformation of business, government, and society. As part of the agreement, the Company has agreed to issue grants to C3.ai DTI, which are subject to compliance with certain obligations. The grants shall be paid by the Company over five years in the form of cash, publicly traded securities, or other property of equivalent net value. As of January 31, 2025 and April 30, 2024, the total potential remaining contributions are $31.6 million and $31.6 million, respectively. The future grant payments are conditional in nature and subject to execution of the program in line with specific requirements. Leases On August 25, 2021, the Company entered into a new lease to acquire approximately 283,015 square feet of office space in several phases in Redwood City, California. The lease commencement date of the first two phases was determined to have occurred in the quarter ended January 31, 2022, when the landlord delivered the leased space to the Company. The lease commencement date of the third phase was determined to have occurred in the quarter ended October 31, 2022, when the landlord delivered the leased space to the Company. The lease commencement date of the fourth phase was determined to have occurred in the quarter ended April 30, 2023, when the landlord delivered the leased space to the Company. The lease commencement date of the fifth phase was determined to have occurred in the quarter ended July 31, 2023, when the landlord delivered the leased space to the Company. The lease commencement date of the sixth phase was determined to have occurred in the quarter ended January 31, 2024, when the landlord delivered the leased space to the Company. The lease commencement date of the seventh and final phase was determined to have occurred in the quarter ended July 31, 2024, when the landlord delivered the applicable leased space to the Company. During the quarter ended January 31, 2025, there was a remeasurement of right-of-use assets and lease liabilities related to phases one, two and six of the lease due to changes in the timing of receipt of lease incentives. As a result, the lease liability for these phases was reduced to $41.3 million and the right-of-use asset correspondingly was reduced to $4.4 million. Legal Proceedings Securities Litigation On March 4, 2022, a putative securities class action complaint (captioned The Reckstin Family Trust v. C3.ai, Inc. et al. , 22-cv-01413-HSG) was filed in the U.S. District Court for the Northern District of California against the Company, and certain current and former officers and directors. On December 12, 2022, the court appointed a lead plaintiff and lead counsel. On February 15, 2023, the lead plaintiff and three additional named plaintiffs filed an amended complaint. The amended complaint names as defendants the Company, four current and former officers and directors, the underwriters in the Company’s initial public offering (“IPO”), and Baker Hughes Company (“Baker Hughes”). The amended complaint generally alleges that the defendants made material misstatements or omissions about the Company’s partnership with Baker Hughes and the Company’s own salesforce. The amended complaint alleges that defendants made these misstatements or omissions in connection with the Company’s IPO in violation of Sections 11 and 15 of the Securities Act of 1933 and between December 9, 2020 and December 2, 2021, inclusive, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The amended complaint further alleges that certain defendants engaged in insider trading in violation of Section 20A of the Securities Exchange Act of 1934. Plaintiffs seek unspecified damages, interest, fees and costs. All defendants moved to dismiss Plaintiffs’ amended complaint on May 1, 2023. On June 30, 2023, Plaintiffs voluntarily dismissed the underwriter defendants. On February 22, 2024, the court granted the motion to dismiss on all claims except for portions of the alleged violations of Section 11 and Section 15. Plaintiffs filed a second amended complaint on April 4, 2024. Defendants filed motions to dismiss on May 17, 2024. Plaintiffs filed an opposition brief on July 15, 2024. While the motions were pending, Plaintiffs filed a motion to amend their second amended complaint on September 27, 2024 to add new factual allegations. The parties have thus stayed the briefing on the motion to dismiss until the motion to amend is resolved. Defendants filed an opposition to the motion to amend on November 12, 2024. On February 13, 2025, the Court granted Plaintiffs’ motion to amend, and the Plaintiffs filed their Third amended complaint on February 14, 2025. Briefing for the revised motion to dismiss is expected to be complete in June 2025. Six putative shareholder derivative actions have been filed: (1) Suri v. Siebel et al. (22-cv-03031) filed on May 23, 2022 in the U.S. District Court for the Northern District of California; (2) Rabasca v. Siebel et al. (23-cv-1566) filed on April 3, 2023 in the U.S. District Court for the Northern District of California; and (3) Vo v. Siebel et al. (23-cv-428) filed on April 19, 2023 in the U.S. District Court for the District of Delaware; and (4) Lanfair v. Siebel et al. (24-cv-01869) filed on March 26, 2024 in the U.S. District Court for the Northern District of California; (5) Pankow v. Siebel et al. (2024-0530-NAC) on May 15, 2024 in the Chancery Court of Delaware; and (6) Rosenfeld v. Siebel et al. (2024-0698) on June 28, 2024 in the Chancery Court of Delaware. In these cases, the plaintiffs assert claims on the Company’s behalf against certain of the Company’s current and former officers and directors for breach of fiduciary duty, aiding and abetting breach of fiduciary duty, gross mismanagement, corporate waste, abuse of control, unjust enrichment, and violations of the Securities Exchange Act of 1934 based on allegations similar to those in the securities class action. In all six cases, the Company is named as a nominal defendant. The derivative complaints seek unspecified damages, disgorgement of profits from board member stock sales, an award of costs and expenses, including reasonable attorneys’ fees, and corporate governance reforms. On September 7, 2022, Suri was stayed pending resolution of the Reckstin case. On August 3, 2023, Vo was transferred to the U.S. District Court for the Northern District of California (3:23-cv-03895), and on August 31, 2023, the Vo action was stayed on the same terms as the Suri action. On December 4, 2023, the parties in Rabasca filed a stipulation to consolidate the Rabasca action with the Suri action, and to stay the Rabasca action on the same terms as the Suri action. On July 3, 2024, Lanfair was consolidated with Suri and stayed on the same terms. The Pankow and Rosenfeld actions have not been consolidated with the Suri action but were stayed on November 13, 2024 and January 15, 2025 respectively. The Company has not yet been required to answer the complaints in any of the derivative actions. As of the date of this report, the Company does not believe it is probable that these cases will result in an unfavorable outcome; however, if an unfavorable outcome were to occur in these cases, it is possible that the impact could be material to the Company’s results of operations in the period(s) in which any such outcome becomes probable and estimable. Given that the litigation is still in its preliminary stages, the Company is currently unable to estimate the potential loss or range of loss, if any, that may arise from these matters. On February 27, 2024, the Company filed a lawsuit in the Court of Rome, Italy against Enel Global Services S.r.l. and any involved corporate affiliates (“Enel”). The claims in the suit against Enel include misappropriation of trade secrets under Articles 98 and 99 of the Italian Industrial Property Code and breach of contract. In this action, the Company seeks compensatory damages in the amount of €2.1 billion, equitable and other relief, as well as fees and costs. The Company has also filed a report of criminal misconduct with Italian law enforcement under Article 623 of the Italian Criminal Code. The Company is evaluating other legal venues to fully redress its claims. The Company is considering filing a report of misconduct with federal law enforcement in the United States. Since any legal action is unpredictable, it is difficult to quantify the potential recoveries, associated potential costs, and timeline associated with resolution of this matter. Any gain on this matter is considered a gain contingency and will be recognized in the period in which the award is realized or realizable. In addition, from time to time, the Company is involved in various other legal proceedings arising in the ordinary course of business. Apart from the foregoing, the Company is not presently a party to any other such litigation the outcome of which, the Company believes, if determined adversely to the Company, would individually, or taken together, have a material adverse effect on the Company’s business, operating results, cash flows, or financial condition."]

{"sheet":"Stockholders' Equity","index":15,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Stockholders' Equity","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Equity [Abstract]"," "]
["Stockholders' Equity","Stockholders’ Equity Preferred Stock The Company has authorized 200,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of January 31, 2025, there were no shares of Preferred Stock issued or outstanding. Common Stock The Company has authorized 1,000,000,000 shares of Class A common stock and 3,500,000 shares of Class B common stock. The shares of Class A common stock and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to 50 votes. Class A and Class B common stock have a par value of $0.001 per share and are referred to as common stock throughout the notes to the unaudited condensed consolidated financial statements, unless otherwise noted. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. Each share of Class B common stock will be automatically converted into one share of Class A common stock upon the earliest of the following: (i) the date that is six months following the death or incapacity of Mr. Siebel; (ii) the date that is six months following the date that Mr. Siebel is no longer providing services to the Company as an officer, employee, director, or consultant; (iii) December 11, 2040, which is the twentieth anniversary of the completion of the IPO; or (iv) the date specified by the holders of a majority of the then outstanding shares of Class B common stock, voting as a separate class. Future transfers by holders of Class B common stock will generally result in those shares converting to Class A common stock."]

{"sheet":"Stock-Based Compensation","index":16,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Stock-Based Compensation","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Share-Based Payment Arrangement [Abstract]"," "]
["Stock-Based Compensation","Stock-Based Compensation On November 27, 2020, the Company’s board of directors adopted, and its stockholders approved, the 2020 Incentive Plan, which became effective in connection with the IPO. The 2020 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit (“RSU”) awards, performance awards and other equity awards. The number of shares of Class A common stock reserved for issuance under the 2020 Incentive Plan is subject to automatic evergreen increases annually through (and including) May 1, 2030 pursuant to the terms of the 2020 Incentive Plan. There was an automatic annual increase on May 1, 2024 in the number of shares reserved for future issuance pursuant to the 2020 Incentive Plan in an amount equal to seven percent (7%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding on April 30, 2024. Stock Options Stock options generally expire 10 years from the date of grant, or earlier if services are terminated. Generally, each stock option for common stock is subject to a vesting schedule such that one fifth of the award vests after the first-year anniversary and one-sixtieth of the award vests each month thereafter over the remaining four years, subject to continuous service. A summary of the Company’s option activity during the nine months ended January 31, 2025 is as follows: Options Outstanding Number of Weighted Weighted Aggregate (in thousands) (in thousands) Balance as of April 30, 2024 31,328 $ 13.97 5.68 $ 268,167 Options granted 1,187 23.43 Options exercised (3,169) 33.66 Options cancelled (540) 26.53 Balance as of January 31, 2025 28,806 $ 15.09 5.23 $ 468,385 Vested and exercisable as of January 31, 2025 23,724 $ 12.17 4.78 $ 455,027 Vested and expected to vest as of January 31, 2025 28,806 $ 15.09 5.23 $ 468,385 As of January 31, 2025, there was $65.4 million of unrecognized compensation cost related to stock options which is expected to be recognized over an estimated weighted-average period of 2.1 years. The grant-date fair value of the options issued for the nine months ended January 31, 2025 is estimated on the date of grant using the Black-Scholes-Merton option pricing model. The weighted average assumptions underlying the fair value estimation are provided in the following table: Nine Months Ended January 31, 2025 2024 Valuation assumptions: Expected dividend yield — % — % Expected volatility 66.2 % 63.5 % Expected term (years) 6.1 6.0 Risk-free interest rate 3.6 % 3.9 % Restricted Stock Units The Company’s RSUs include time-based RSUs and performance-based RSUs with market conditions (“PRSUs”). Time-based RSUs The time-based RSUs are typically subject to service-based vesting conditions satisfied over five years with one-fifth of the award vesting after the first-year anniversary and one-twentieth of the award vesting quarterly thereafter. The related stock-based compensation is recognized on a straight-line basis over the requisite service period. PRSUs In July 2022, the compensation committee of the board of directors (the “Compensation Committee”) approved the grant of a maximum of 1,700,000 performance-based restricted stock units (the “PRSU Award”) to the CEO pursuant to the 2020 Incentive Plan, subject to and conditioned upon the subsequent determination by the board of directors of performance metrics upon the achievement of which the PRSU Award would vest. In August 2022, the board of directors approved performance metrics in concept, subject to further action by the Compensation Committee. In December 2022, the Compensation Committee: (a) determined and approved the performance metrics, which are based on the achievement of certain total shareholder return results, as measured against certain stock price hurdles (the “Market Condition”); and (b) extended the vesting period of the PRSU Award through December 31, 2027. As an additional condition to vesting of each tranche of the PRSU Award, Mr. Siebel must remain in continuous service to the Company through a minimum service date that applies to such tranche or, if later, the date the applicable performance metric is achieved (the “Service Condition”). The grant date of the PRSU Award was established in December 2022. Stock-based compensation expense associated with the PRSU Award will be recognized over the longer of the expected achievement period for the Market Condition or the Service Condition. For the nine months ended January 31, 2025, the Company recorded stock-based compensation expense of $3.1 million related to the PRSU Award. The Company determined the grant date fair value of the PRSU Award using a Monte Carlo simulation model with the following assumptions: stock price of $12.90, risk-free interest rate of 3.7%, dividend yield of 0% and expected volatility of 51.4%. A summary of the Company’s RSU activity during the nine months ended January 31, 2025 is as follows: RSUs Outstanding Number of RSUs Weighted Average (in thousands) Unvested Balance as of April 30, 2024 19,283 $ 24.26 RSUs granted 12,676 29.51 RSUs vested (5,381) 27.54 RSUs forfeited (2,999) 27.46 Unvested Balance as of January 31, 2025 23,579 $ 26.41 As of January 31, 2025, there was $579.8 million of unrecognized stock-based compensation expense related to outstanding RSUs granted to employees that is expected to be recognized over a weighted-average period of 3.8 years. In fiscal year 2025 and 2024, the Compensation Committee approved the payment of fiscal year 2024 and 2023 bonuses, respectively, under the Company’s annual bonus program in the form of fully vested RSUs covering shares of Class A common stock to employees. The Company issued 751,927 and 532,842 shares of Class A common stock pursuant to this program in the nine months ended January 31, 2025 and 2024, respectively. Shares issued in settlement of fully vested RSUs granted under this bonus program were issued from the 2020 Incentive Plan and reduced the shares available for issuance under the 2020 Incentive Plan. Employee Stock Purchase Plan On November 27, 2020, the Company’s board of directors also adopted, and its stockholders also approved, the 2020 Employee Stock Purchase Plan (the “2020 ESPP”), which became effective immediately prior to the IPO. The 2020 ESPP authorizes the issuance of shares of Class A common stock pursuant to purchase rights granted to employees. A total of 3,000,000 shares of Class A common stock were initially reserved for future issuance under the 2020 ESPP. The number of shares of Class A common stock reserved for issuance under the 2020 ESPP is subject to automatic evergreen increases annually through (and including) May 1, 2030 pursuant to the terms of the 2020 ESPP. There was an automatic annual increase on May 1, 2024 in the number of shares reserved for future issuance pursuant to the 2020 ESPP in an amount equal to one percent (1%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding on April 30, 2024. The 2020 ESPP permits participants to purchase shares of Class A common stock in an amount not exceeding 15% of their earnings during the relevant offering period. The offering dates and purchase dates for the 2020 ESPP are determined at the discretion of the Company’s board of directors. Except for the initial offering period under the 2020 ESPP, which commenced on October 16, 2022 and ended on September 15, 2024, the 2020 ESPP provides for 24-month offering periods beginning September 15 and March 15 of each year, with each offering period consisting of four six-month purchase periods. The 2020 ESPP allows eligible employees to purchase shares of the Company’s Class A common stock, subject to purchase limits of 2,500 shares during each six-month period or $25,000 worth of stock for each calendar year, through payroll deductions at price per share equal to 85% of the lesser of the fair market value of the Company’s Class A common stock on (i) the first trading day of the applicable offering period and (ii) the last trading day of each purchase period in the applicable offering period. If the price per share of the Company’s Class A common stock on any purchase date in the offering period is lower than the price per share of the Company’s Class A common stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new 24-month offering period. The Company uses a Black-Scholes-Merton option pricing model to determine the fair value of employee stock purchase rights granted under the 2020 ESPP. The following assumptions were used to calculate the fair value of shares to be granted under the 2020 ESPP during the period: Nine Months Ended January 31, 2025 2024 Valuation assumptions: Expected dividend yield — % — % Expected volatility 56.2 - 75.3% 64.0 - 70.1% Expected term (years) 0.5 - 2.0 0.5 - 2.0 Risk-free interest rate 3.6 - 4.6% 5.0 - 5.5% During the nine months ended January 31, 2025 and 2024, the Company recognized $4.4 million and $4.3 million, respectively, of stock-based compensation expense related to 2020 ESPP. As of January 31, 2025, there was $5.7 million of unrecognized stock-based compensation expense that is expected to be recognized over the remaining term of the respective offering periods. Stock-based Compensation Expense The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2025 2024 2025 2024 Cost of subscription $ 8,563 $ 8,674 $ 24,084 $ 25,244 Cost of professional services 941 309 2,139 1,248 Sales and marketing 21,860 17,528 61,495 52,533 Research and development 19,896 18,757 56,326 52,475 General and administrative 11,392 9,715 30,329 27,532 Total stock-based compensation expense $ 62,652 $ 54,983 $ 174,373 $ 159,032 The Company records stock-based compensation associated with the Company’s annual bonus program and retention bonus program for certain employees, which may be paid out in fully vested RSUs that are settled in shares of Class A common stock. During the nine months ended January 31, 2025, the Company recognized $37.6 million of stock-based compensation expense associated with these programs. As of January 31, 2025, $32.9 million was reflected under accrued compensation and employee benefits in the consolidated balance sheets. Upon settlement, this amount will be reflected under common stock and additional paid-in capital in the condensed consolidated statements of stockholders’ equity."]

{"sheet":"Income Taxes","index":17,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Income Taxes","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Income Tax Disclosure [Abstract]"," "]
["Income Taxes","Income Taxes Accounting for income taxes for interim periods generally requires the provision for income taxes to be determined by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss before income taxes, adjusted for discrete items, if any, for the reporting period. The Company updates its estimate of the annual effective tax rate each quarter and makes a cumulative adjustment in such period. The Company recorded income tax expense of $0.3 million and $0.5 million for the three months ended January 31, 2025 and 2024, and $0.9 million and $0.9 million for the nine months ended January 31, 2025 and 2024, respectively. Income tax expense consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. Due to the Company’s history of losses in the United States, a full valuation allowance on substantially all of the Company’s deferred tax assets, including net operating loss carryforwards, research and development tax credits, and other book versus tax differences, was maintained."]

{"sheet":"Net Loss Per Share Attributable","index":18,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Net Loss Per Share Attributable to Common Stockholders","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Earnings Per Share [Abstract]"," "]
["Net Loss Per Share Attributable to Common Stockholders","Net Loss Per Share Attributable to Common Stockholders Basic net loss per share was the same as diluted net loss per share for the periods presented because the Company was in a loss position for the three and nine months ended January 31, 2025 and 2024. For purposes of this calculation, stock options, RSUs, Class A common stock issuable in connection with the 2020 ESPP and early exercised stock options subject to repurchase are considered to be potential common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended January 31, Nine Months Ended January 31, 2025 2024 2025 2024 Numerator Net loss attributable to common stockholders $ (80,201) $ (72,631) $ (209,000) $ (206,769) Denominator Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 130,382 120,486 127,752 118,259 Basic and diluted net loss per share attributable to common stockholders Basic and diluted net loss per Class A and Class B common shares $ (0.62) $ (0.60) $ (1.64) $ (1.75) The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an antidilutive effect were as follows (in thousands): As of January 31, 2025 2024 Stock options 28,806 32,103 RSUs 23,579 20,908 ESPP 975 1,102 "]

{"sheet":"Related Party Transactions","index":19,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Related Party Transactions","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Related Party Transactions [Abstract]"," "]
["Related Party Transactions","Related Party Transactions Revenue Transactions with Baker Hughes Company In June 2019, the Company entered into multiple agreements with Baker Hughes, which were subsequently modified in June 2020, October 2021 and January 2023. Details of these agreements are discussed in Note 12. Related Party Transactions in the Notes to Consolidated Financial Statements in the Annual Report on Form 10-K for the fiscal year ended April 30, 2024, which was filed with the SEC on June 18, 2024. Baker Hughes ceased to qualify as a related party of the Company as of June 30, 2023 and the amounts disclosed related to them are accordingly presented only for the periods in which they were considered a related party. The Company recognized subscription revenue from direct subscription fees from Baker Hughes of $10.6 million during the nine months ended January 31, 2024. The Company recognized professional services revenue from Baker Hughes of $5.8 million during the nine months ended January 31, 2024. The Company recognized sales and marketing expenses related to Baker Hughes of $0.8 million (inclusive of amortization of $0.8 million of deferred commissions) during the nine months ended January 31, 2024. Sublease Arrangement On February 21, 2023, the Company entered into a sublease agreement (the “Sublease”) with First Virtual Group, Inc. (the “Subtenant”), whereby the Company agreed to sublease to the Subtenant approximately 3,130 square feet of space located in Redwood City, California (the “Subleased Space”). The Company previously entered into a lease (the “Original Lease”) with DWF IV 1400-1500 Seaport Blvd, LLC dated August 25, 2021 for approximately 283,013 square feet of office space split between two office towers, including the Subleased Space. Thomas M. Siebel, Chief Executive Officer and Chairman of the Company, serves as Chairman of the Subtenant. The term of the Sublease commenced on February 1, 2023. The Sublease was automatically renewed on October 1, 2023 and will be automatically renewed for successive one year periods thereafter unless the Subtenant notifies the Company of its election to terminate the Sublease, up to the expiration date of the Original Lease. The monthly base rent for the Sublease is equal to the rate per square foot paid by the Company as stated in the Original Lease. The monthly base rent the Subtenant pays was approximately $8,608 through September 30, 2023, increasing annually thereafter. In addition to base rent, the Subtenant is responsible for its allocated share of costs incurred and expenditures made by the Company in the operation and management of the Subleased Space."]

{"sheet":"Pay vs Performance Disclosure","index":20,"n_rows":4,"n_cols":5,"rows_kept":4,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Pay vs Performance Disclosure - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Pay vs Performance Disclosure"," "," "," "," "]
["Net loss",{"v":-80201,"d":"$ (80,201)"},{"v":-72631,"d":"$ (72,631)"},{"v":-209000,"d":"$ (209,000)"},{"v":-206769,"d":"$ (206,769)"}]

{"sheet":"Insider Trading Arrangements","index":21,"n_rows":7,"n_cols":2,"rows_kept":7,"merged":[[0,0,1,0]]}
["Insider Trading Arrangements","3 Months Ended"]
[null,"Jan. 31, 2025"]
["Trading Arrangements, by Individual"," "]
["Rule 10b5-1 Arrangement Adopted","false"]
["Non-Rule 10b5-1 Arrangement Adopted","false"]
["Rule 10b5-1 Arrangement Terminated","false"]
["Non-Rule 10b5-1 Arrangement Terminated","false"]

{"sheet":"Summary of Business and Signi_2","index":22,"n_rows":8,"n_cols":2,"rows_kept":8,"merged":[[0,0,1,0]]}
["Summary of Business and Significant Accounting Policies (Policies)","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Basis of Presentation","Basis of Presentation and Principles of Consolidation The Company prepares its unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2024, which was filed with the SEC on June 18, 2024. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of January 31, 2025 and the results of operations for the three and nine months ended January 31, 2025, and cash flows for the nine months ended January 31, 2025. The results of operations for the three and nine months ended January 31, 2025 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period."]
["Principles of Consolidation","The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation."]
["Use of Estimates","Use of Estimates The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Such estimates include, but are not limited to, determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases, other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions."]
["Fiscal Year","Fiscal Year The Company’s fiscal year ends on April 30."]
["Recently Issued Accounting Standards Not Yet Adopted","Recently Issued Accounting Standards Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to improve the disclosures regarding a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The Company is required to adopt the guidance in the fourth quarter of fiscal 2025, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures (“ASU 2023-09”) to provide disaggregated income tax disclosures on rate reconciliation and income taxes paid. The Company is required to adopt the guidance in the fourth quarter of fiscal 2026, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements. In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income (Topic 220) Disaggregation of Income Statement Expenses (“ASU 2024-03”), to enhance the transparency and decision usefulness of financial information presented in the income statement by requiring disaggregated information about certain income statement expense line items. The Company is required to adopt the guidance in the fourth quarter of fiscal 2028, though early adoption permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements."]

{"sheet":"Revenue (Tables)","index":23,"n_rows":5,"n_cols":2,"rows_kept":5,"merged":[[0,0,1,0]]}
["Revenue (Tables)","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Revenue from Contract with Customer [Abstract]"," "]
["Schedule of Revenue by Geographical Region","The following table presents revenue by geographical region (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2025 2024 2025 2024 North America (1) $ 87,289 $ 68,356 $ 248,838 $ 191,247 Europe, the Middle East and Africa (1) 11,085 9,040 29,978 29,205 Asia Pacific (1) 13 952 274 2,877 Rest of World (1) 395 53 1,243 663 Total revenue $ 98,782 $ 78,401 $ 280,333 $ 223,992 __________________ (1) The United States comprised 86% and 86% of the Company’s revenue for the three months ended January 31, 2025 and 2024, respectively, and 87% and 85% of the Company’s revenue for the nine months ended January 31, 2025 and 2024, respectively. No other country comprised 10% or greater of the Company’s revenue for the three and nine months ended January 31, 2025 or 2024."]
["Professional Services Revenue","Total professional services revenue comprised of (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2025 2024 2025 2024 Prioritized engineering services $ 5,698 $ 7,125 $ 26,008 $ 20,225 Service fees 7,405 876 14,028 5,566 Total professional services revenue $ 13,103 $ 8,001 $ 40,036 $ 25,791 "]

{"sheet":"Fair Value Measurements (Tables","index":24,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Fair Value Measurements (Tables)","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Fair Value Disclosures [Abstract]"," "]
["Schedule of Assets Measured at Fair Value on a Recurring Basis","The following table summarizes the types of assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): As of January 31, 2025 As of April 30, 2024 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 77,902 $ — $ — $ 77,902 $ 82,564 $ — $ — $ 82,564 Commercial paper — 6,971 — 6,971 — 18,769 — 18,769 U.S. treasury securities — — — — — 5,888 — 5,888 Certificates of deposit — 3,960 — 3,960 — — — — Available-for-sale marketable securities: U.S. treasury securities — 14,395 — 14,395 — 2,497 — 2,497 Certificates of deposit — 84,645 — 84,645 — 62,017 — 62,017 U.S. government agencies securities — 60,457 — 60,457 — 46,428 — 46,428 Commercial paper — 108,045 — 108,045 — 162,183 — 162,183 Corporate debt securities — 331,691 — 331,691 — 310,095 — 310,095 Total cash equivalents and available-for-sale marketable securities $ 77,902 $ 610,164 $ — $ 688,066 $ 82,564 $ 607,877 $ — $ 690,441 "]

{"sheet":"Cash Equivalents and Marketab_2","index":25,"n_rows":6,"n_cols":2,"rows_kept":6,"merged":[[0,0,1,0]]}
["Cash Equivalents and Marketable Securities (Tables)","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Investments, Debt and Equity Securities [Abstract]"," "]
["Schedule of Available-For-Sale Debt Securities and Balance Sheet Classification","The following table summarizes the Company’s cash equivalents and available-for-sale marketable securities (in thousands): As of January 31, 2025 As of April 30, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 77,902 $ — $ — $ 77,902 $ 82,564 $ — $ — $ 82,564 Commercial paper 6,971 — — 6,971 18,769 — — 18,769 U.S. treasury securities — — — — 5,888 — — 5,888 Certificates of deposit 3,960 — — 3,960 — — — — Available-for-sale marketable securities: U.S. treasury securities 14,382 13 — 14,395 2,497 — — 2,497 Certificates of deposit 84,645 — — 84,645 62,017 — — 62,017 U.S. government agencies securities 60,536 76 (155) 60,457 46,527 5 (104) 46,428 Commercial paper 108,045 — — 108,045 162,183 — — 162,183 Corporate debt securities 331,331 679 (319) 331,691 310,557 64 (526) 310,095 Total cash equivalents and available-for-sale marketable securities $ 687,772 $ 768 $ (474) $ 688,066 $ 691,002 $ 69 $ (630) $ 690,441 "]
["Summary of Available-For-Sale Debt Securities by Contractual Maturity","The following table summarizes the Company’s available-for-sale marketable securities by contractual maturity (in thousands): As of January 31, 2025 As of April 30, 2024 Amortized Cost Fair Value Amortized Cost Fair Value Within one year $ 494,233 $ 494,937 $ 514,747 $ 514,484 After one year through five years 104,706 104,296 69,034 68,736 Total $ 598,939 $ 599,233 $ 583,781 $ 583,220 "]
["Summary of Available-For-Sale Marketable Securities, Fair Values and Unrealized Losses","The following table summarizes the fair values and unrealized losses of the Company’s available-for-sale marketable securities classified by length of time that the securities have been in a continuous unrealized loss position but were not deemed to be other-than-temporarily impaired (in thousands): As of January 31, 2025 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. government agencies securities $ (155) $ 18,817 $ — $ — $ (155) $ 18,817 Commercial paper — 3,517 — — — 3,517 Corporate debt securities (319) 37,727 — — (319) 37,727 Total $ (474) $ 60,061 $ — $ — $ (474) $ 60,061 As of April 30, 2024 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. treasury securities $ — $ 2,497 $ — $ — $ — $ 2,497 U.S. government agencies securities (99) 33,890 (6) 7,749 (105) 41,639 Commercial paper — 4,058 — — — 4,058 Corporate debt securities (491) 196,907 (34) 27,658 (525) 224,565 Total $ (590) $ 237,352 $ (40) $ 35,407 $ (630) $ 272,759 "]

{"sheet":"Balance Sheet Details (Tables)","index":26,"n_rows":6,"n_cols":2,"rows_kept":6,"merged":[[0,0,1,0]]}
["Balance Sheet Details (Tables)","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Schedule of Property and Equipment, Net","Property and equipment consisted of the following at January 31, 2025 and April 30, 2024 (in thousands): Useful Life As of January 31, As of April 30, (in months) 2025 2024 Leasehold improvements * $ 82,507 $ 71,867 Computer equipment 36 6,702 4,936 Office furniture and equipment 60 15,517 14,479 Capital work-in-progress NA 811 12,122 Property and equipment, gross 105,537 103,404 Less: accumulated depreciation and amortization (23,627) (14,773) Property and equipment, net $ 81,910 $ 88,631 __________________ * Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. NA = Not Applicable"]
["Schedule of Accrued Compensation and Employee Benefits","Accrued compensation and employee benefits consisted of the following at January 31, 2025 and April 30, 2024 (in thousands): As of January 31, As of April 30, 2025 2024 Accrued bonus $ 32,875 $ 31,530 Accrued vacation 3,918 4,317 Accrued payroll taxes and benefits 1,959 3,636 Accrued commissions 5,116 2,826 ESPP contributions 4,596 1,409 Other 263 545 Accrued compensation and employee benefits $ 48,727 $ 44,263 "]
["Schedule of Accrued and Other Current Liabilities","Accrued and other current liabilities consisted of the following at January 31, 2025 and April 30, 2024 (in thousands): As of January 31, As of April 30, 2025 2024 Accrued general expenses 3,678 2,783 Operating lease liabilities, current 4,490 3,226 Accrued professional services 7,008 2,082 Accrued cloud hosting services 6,687 643 Accrued taxes payable 2,744 621 Other 3,021 171 Accrued and other current liabilities $ 27,628 $ 9,526 "]

{"sheet":"Stock-Based Compensation (Table","index":27,"n_rows":7,"n_cols":2,"rows_kept":7,"merged":[[0,0,1,0]]}
["Stock-Based Compensation (Tables)","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Share-Based Payment Arrangement [Abstract]"," "]
["Summary of Stock Option Activity","A summary of the Company’s option activity during the nine months ended January 31, 2025 is as follows: Options Outstanding Number of Weighted Weighted Aggregate (in thousands) (in thousands) Balance as of April 30, 2024 31,328 $ 13.97 5.68 $ 268,167 Options granted 1,187 23.43 Options exercised (3,169) 33.66 Options cancelled (540) 26.53 Balance as of January 31, 2025 28,806 $ 15.09 5.23 $ 468,385 Vested and exercisable as of January 31, 2025 23,724 $ 12.17 4.78 $ 455,027 Vested and expected to vest as of January 31, 2025 28,806 $ 15.09 5.23 $ 468,385 "]
["Schedule of Valuation Assumptions","The weighted average assumptions underlying the fair value estimation are provided in the following table: Nine Months Ended January 31, 2025 2024 Valuation assumptions: Expected dividend yield — % — % Expected volatility 66.2 % 63.5 % Expected term (years) 6.1 6.0 Risk-free interest rate 3.6 % 3.9 % The following assumptions were used to calculate the fair value of shares to be granted under the 2020 ESPP during the period: Nine Months Ended January 31, 2025 2024 Valuation assumptions: Expected dividend yield — % — % Expected volatility 56.2 - 75.3% 64.0 - 70.1% Expected term (years) 0.5 - 2.0 0.5 - 2.0 Risk-free interest rate 3.6 - 4.6% 5.0 - 5.5%"]
["Schedule of Restricted Stock Unit Activity","A summary of the Company’s RSU activity during the nine months ended January 31, 2025 is as follows: RSUs Outstanding Number of RSUs Weighted Average (in thousands) Unvested Balance as of April 30, 2024 19,283 $ 24.26 RSUs granted 12,676 29.51 RSUs vested (5,381) 27.54 RSUs forfeited (2,999) 27.46 Unvested Balance as of January 31, 2025 23,579 $ 26.41 "]
["Summary of Effects of Stock-Based Compensation","The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2025 2024 2025 2024 Cost of subscription $ 8,563 $ 8,674 $ 24,084 $ 25,244 Cost of professional services 941 309 2,139 1,248 Sales and marketing 21,860 17,528 61,495 52,533 Research and development 19,896 18,757 56,326 52,475 General and administrative 11,392 9,715 30,329 27,532 Total stock-based compensation expense $ 62,652 $ 54,983 $ 174,373 $ 159,032 "]

{"sheet":"Net Loss Per Share Attributab_2","index":28,"n_rows":5,"n_cols":2,"rows_kept":5,"merged":[[0,0,1,0]]}
["Net Loss Per Share Attributable to Common Stockholders (Tables)","9 Months Ended"]
[null,"Jan. 31, 2025"]
["Earnings Per Share [Abstract]"," "]
["Schedule of Basic and Diluted Net Loss Per Share","The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended January 31, Nine Months Ended January 31, 2025 2024 2025 2024 Numerator Net loss attributable to common stockholders $ (80,201) $ (72,631) $ (209,000) $ (206,769) Denominator Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 130,382 120,486 127,752 118,259 Basic and diluted net loss per share attributable to common stockholders Basic and diluted net loss per Class A and Class B common shares $ (0.62) $ (0.60) $ (1.64) $ (1.75)"]
["Schedule of Potential Shares of Common Stock Excluded from Computation of Basic and Diluted Net Loss Per Share","The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an antidilutive effect were as follows (in thousands): As of January 31, 2025 2024 Stock options 28,806 32,103 RSUs 23,579 20,908 ESPP 975 1,102 "]

{"sheet":"Revenue - Disaggregated Revenue","index":29,"n_rows":22,"n_cols":5,"rows_kept":22,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Revenue - Disaggregated Revenue by Geographic Region (Details) - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Total revenue",{"v":98782,"d":"$ 98,782"},{"v":78401,"d":"$ 78,401"},{"v":280333,"d":"$ 280,333"},{"v":223992,"d":"$ 223,992"}]
["Software Licenses"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Total revenue",{"v":28600,"d":"28,600 "},{"v":8400,"d":"8,400 "},{"v":60400,"d":"60,400 "},{"v":15400,"d":"15,400 "}]
["North America"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Total revenue",{"v":87289,"d":"$ 87,289"},{"v":68356,"d":"$ 68,356"},{"v":248838,"d":"$ 248,838"},{"v":191247,"d":"$ 191,247"}]
["United States | Revenue | Geographic Concentration Risk"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Geographic concentration risk, percentage",{"v":0.86,"d":"86%"},{"v":0.86,"d":"86%"},{"v":0.87,"d":"87%"},{"v":0.85,"d":"85%"}]
["Europe, the Middle East and Africa"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Total revenue",{"v":11085,"d":"$ 11,085"},{"v":9040,"d":"$ 9,040"},{"v":29978,"d":"$ 29,978"},{"v":29205,"d":"$ 29,205"}]
["Asia Pacific"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Total revenue",{"v":13,"d":"13 "},{"v":952,"d":"952 "},{"v":274,"d":"274 "},{"v":2877,"d":"2,877 "}]
["Rest of World"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Total revenue",{"v":395,"d":"$ 395"},{"v":53,"d":"$ 53"},{"v":1243,"d":"$ 1,243"},{"v":663,"d":"$ 663"}]

{"sheet":"Revenue - Professional Services","index":30,"n_rows":15,"n_cols":6,"rows_kept":15,"merged":[[0,0,1,1],[0,2,0,3],[0,4,0,5],[13,0,13,4],[14,0,14,4]]}
["Revenue - Professional Services Revenue (Details) - USD ($) $ in Thousands",null,"3 Months Ended",null,"9 Months Ended"]
[null,null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Disaggregation of Revenue [Line Items]",null," "," "," "," "]
["Total professional services revenue",null,{"v":98782,"d":"$ 98,782"},{"v":78401,"d":"$ 78,401"},{"v":280333,"d":"$ 280,333"},{"v":223992,"d":"$ 223,992"}]
["Prioritized engineering services",null," "," "," "," "]
["Disaggregation of Revenue [Line Items]",null," "," "," "," "]
["Total professional services revenue",null,{"v":5698,"d":"5,698 "},{"v":7125,"d":"7,125 "},{"v":26008,"d":"26,008 "},{"v":20225,"d":"20,225 "}]
["Service fees",null," "," "," "," "]
["Disaggregation of Revenue [Line Items]",null," "," "," "," "]
["Total professional services revenue",null,{"v":7405,"d":"7,405 "},{"v":876,"d":"876 "},{"v":14028,"d":"14,028 "},{"v":5566,"d":"5,566 "}]
["Professional services",null," "," "," "," "]
["Disaggregation of Revenue [Line Items]",null," "," "," "," "]
["Total professional services revenue","[1]",{"v":13103,"d":"$ 13,103"},{"v":8001,"d":"$ 8,001"},{"v":40036,"d":"$ 40,036"},{"v":25791,"d":"$ 25,791"}]
[]
["[1]Including related party revenue of $5,804 for the nine months ended January 31, 2024."]

{"sheet":"Revenue - Deferred Revenue (Det","index":31,"n_rows":5,"n_cols":4,"rows_kept":5,"merged":[[0,0,1,0],[0,1,0,2]]}
["Revenue - Deferred Revenue (Details) - USD ($) $ in Millions","9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Apr. 30, 2024"]
["Revenue from Contract with Customer [Abstract]"," "," "," "]
["Contract with customer, liability",{"v":33,"d":"$ 33"}," ",{"v":39,"d":"$ 39"}]
["Revenue recognized",{"v":37.8,"d":"$ 37.8"},{"v":46.3,"d":"$ 46.3"}," "]

{"sheet":"Revenue - Remaining Performance","index":32,"n_rows":15,"n_cols":2,"rows_kept":15,"merged":[[0,0,1,0]]}
["Revenue - Remaining Performance Obligation (Details) $ in Millions","9 Months Ended"]
[null,"Jan. 31, 2025 USD ($)"]
["Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"," "]
["Revenue expected to be recognized from remaining performance obligations, amount",{"v":208.2,"d":"$ 208.2"}]
["Non-cancellable commitments",74.6]
["Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-11-01"," "]
["Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"," "]
["Revenue expected to be recognized from remaining performance obligations, amount",{"v":124,"d":"$ 124"}]
["Revenue expected to be recognized from remaining performance obligations, period","12 months"]
["Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-11-01 | Minimum"," "]
["Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"," "]
["Revenue expected to be recognized from remaining performance obligations, period","13 months"]
["Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-11-01 | Maximum"," "]
["Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"," "]
["Revenue expected to be recognized from remaining performance obligations, period","48 months"]

{"sheet":"Revenue - Customer Concentratio","index":33,"n_rows":22,"n_cols":6,"rows_kept":22,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Revenue - Customer Concentration and Accounts Receivable (Details) - USD ($) $ in Millions","3 Months Ended",null,"9 Months Ended",null,"12 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024","Apr. 30, 2024"]
["Disaggregation of Revenue [Line Items]"," "," "," "," "," "]
["Unbilled receivables",{"v":89.8,"d":"$ 89.8"}," ",{"v":89.8,"d":"$ 89.8"}," ",{"v":62.3,"d":"$ 62.3"}]
["Customer Concentration Risk | Revenue | Customer One"," "," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "," "]
["Customer concentration risk, percentage",{"v":0.15,"d":"15%"},{"v":0.25,"d":"25%"},{"v":0.18,"d":"18%"},{"v":0.27,"d":"27%"}," "]
["Customer Concentration Risk | Revenue | Customer Two"," "," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "," "]
["Customer concentration risk, percentage",{"v":0.1,"d":"10%"},{"v":0.12,"d":"12%"}," ",{"v":0.13,"d":"13%"}," "]
["Customer Concentration Risk | Accounts Receivable | Customer One"," "," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "," "]
["Customer concentration risk, percentage"," "," ",{"v":0.14,"d":"14%"}," ",{"v":0.25,"d":"25%"}]
["Customer Concentration Risk | Accounts Receivable | Customer Two"," "," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "," "]
["Customer concentration risk, percentage"," "," ",{"v":0.14,"d":"14%"}," ",{"v":0.16,"d":"16%"}]
["Customer Concentration Risk | Accounts Receivable | Customer Three"," "," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "," "]
["Customer concentration risk, percentage"," "," ",{"v":0.13,"d":"13%"}," "," "]
["Customer Concentration Risk | Accounts Receivable | Customer Four"," "," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "," "]
["Customer concentration risk, percentage"," "," ",{"v":0.11,"d":"11%"}," "," "]

{"sheet":"Fair Value Measurements - Asset","index":34,"n_rows":135,"n_cols":3,"rows_kept":135}
["Fair Value Measurements - Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024"]
["Available-for-sale marketable securities:"," "," "]
["Total cash equivalents and available-for-sale marketable securities",{"v":688066,"d":"$ 688,066"},{"v":690441,"d":"$ 690,441"}]
["Money market funds"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":77902,"d":"77,902 "},{"v":82564,"d":"82,564 "}]
["Commercial paper"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":6971,"d":"6,971 "},{"v":18769,"d":"18,769 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":108045,"d":"108,045 "},{"v":162183,"d":"162,183 "}]
["U.S. treasury securities"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":5888,"d":"5,888 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":14395,"d":"14,395 "},{"v":2497,"d":"2,497 "}]
["Certificates of deposit"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":3960,"d":"3,960 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":84645,"d":"84,645 "},{"v":62017,"d":"62,017 "}]
["U.S. government agencies securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":60457,"d":"60,457 "},{"v":46428,"d":"46,428 "}]
["Corporate debt securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":331691,"d":"331,691 "},{"v":310095,"d":"310,095 "}]
["Fair Value, Recurring"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Total cash equivalents and available-for-sale marketable securities",{"v":688066,"d":"688,066 "},{"v":690441,"d":"690,441 "}]
["Fair Value, Recurring | Money market funds"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":77902,"d":"77,902 "},{"v":82564,"d":"82,564 "}]
["Fair Value, Recurring | Commercial paper"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":6971,"d":"6,971 "},{"v":18769,"d":"18,769 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":108045,"d":"108,045 "},{"v":162183,"d":"162,183 "}]
["Fair Value, Recurring | U.S. treasury securities"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":5888,"d":"5,888 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":14395,"d":"14,395 "},{"v":2497,"d":"2,497 "}]
["Fair Value, Recurring | Certificates of deposit"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":3960,"d":"3,960 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":84645,"d":"84,645 "},{"v":62017,"d":"62,017 "}]
["Fair Value, Recurring | U.S. government agencies securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":60457,"d":"60,457 "},{"v":46428,"d":"46,428 "}]
["Fair Value, Recurring | Corporate debt securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":331691,"d":"331,691 "},{"v":310095,"d":"310,095 "}]
["Fair Value, Recurring | Level 1"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Total cash equivalents and available-for-sale marketable securities",{"v":77902,"d":"77,902 "},{"v":82564,"d":"82,564 "}]
["Fair Value, Recurring | Level 1 | Money market funds"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":77902,"d":"77,902 "},{"v":82564,"d":"82,564 "}]
["Fair Value, Recurring | Level 1 | Commercial paper"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 1 | U.S. treasury securities"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 1 | Certificates of deposit"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 1 | U.S. government agencies securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 1 | Corporate debt securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 2"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Total cash equivalents and available-for-sale marketable securities",{"v":610164,"d":"610,164 "},{"v":607877,"d":"607,877 "}]
["Fair Value, Recurring | Level 2 | Money market funds"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 2 | Commercial paper"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":6971,"d":"6,971 "},{"v":18769,"d":"18,769 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":108045,"d":"108,045 "},{"v":162183,"d":"162,183 "}]
["Fair Value, Recurring | Level 2 | U.S. treasury securities"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":5888,"d":"5,888 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":14395,"d":"14,395 "},{"v":2497,"d":"2,497 "}]
["Fair Value, Recurring | Level 2 | Certificates of deposit"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":3960,"d":"3,960 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":84645,"d":"84,645 "},{"v":62017,"d":"62,017 "}]
["Fair Value, Recurring | Level 2 | U.S. government agencies securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":60457,"d":"60,457 "},{"v":46428,"d":"46,428 "}]
["Fair Value, Recurring | Level 2 | Corporate debt securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":331691,"d":"331,691 "},{"v":310095,"d":"310,095 "}]
["Fair Value, Recurring | Level 3"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Total cash equivalents and available-for-sale marketable securities",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 3 | Money market funds"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 3 | Commercial paper"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 3 | U.S. treasury securities"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 3 | Certificates of deposit"," "," "]
["Cash equivalents:"," "," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 3 | U.S. government agencies securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Fair Value, Recurring | Level 3 | Corporate debt securities"," "," "]
["Available-for-sale marketable securities:"," "," "]
["Available-for-sale marketable securities, fair value",{"v":0,"d":"$ 0"},{"v":0,"d":"$ 0"}]

{"sheet":"Cash Equivalents and Marketab_3","index":35,"n_rows":59,"n_cols":4,"rows_kept":59}
["Cash Equivalents and Marketable Securities - Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024","Jan. 31, 2024"]
["Cash equivalents:"," "," "," "]
["Amortized Cost",{"v":125094,"d":"$ 125,094"},{"v":167146,"d":"$ 167,146"},{"v":114561,"d":"$ 114,561"}]
["Debt Securities, Available-for-Sale [Abstract]"," "," "," "]
["Total cash equivalents and available-for-sale marketable securities, Amortized Cost",{"v":687772,"d":"687,772 "},{"v":691002,"d":"691,002 "}," "]
["Total cash equivalents and available-for-sale marketable securities, Gross Unrealized Gain",{"v":768,"d":"768 "},{"v":69,"d":"69 "}," "]
["Total cash equivalents and available-for-sale marketable securities, Gross Unrealized Loss",{"v":-474,"d":"(474)"},{"v":-630,"d":"(630)"}," "]
["Total cash equivalents and available-for-sale marketable securities",{"v":688066,"d":"688,066 "},{"v":690441,"d":"690,441 "}," "]
["Money market funds"," "," "," "]
["Cash equivalents:"," "," "," "]
["Amortized Cost",{"v":77902,"d":"77,902 "},{"v":82564,"d":"82,564 "}," "]
["Gross Unrealized Gains",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Gross Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Estimated Fair Value",{"v":77902,"d":"77,902 "},{"v":82564,"d":"82,564 "}," "]
["Commercial paper"," "," "," "]
["Cash equivalents:"," "," "," "]
["Amortized Cost",{"v":6971,"d":"6,971 "},{"v":18769,"d":"18,769 "}," "]
["Gross Unrealized Gains",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Gross Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Estimated Fair Value",{"v":6971,"d":"6,971 "},{"v":18769,"d":"18,769 "}," "]
["Debt Securities, Available-for-Sale [Abstract]"," "," "," "]
["Amortized Cost",{"v":108045,"d":"108,045 "},{"v":162183,"d":"162,183 "}," "]
["Gross Unrealized Gains",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Gross Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Estimated Fair Value",{"v":108045,"d":"108,045 "},{"v":162183,"d":"162,183 "}," "]
["U.S. treasury securities"," "," "," "]
["Cash equivalents:"," "," "," "]
["Amortized Cost",{"v":0,"d":"0 "},{"v":5888,"d":"5,888 "}," "]
["Gross Unrealized Gains",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Gross Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Estimated Fair Value",{"v":0,"d":"0 "},{"v":5888,"d":"5,888 "}," "]
["Debt Securities, Available-for-Sale [Abstract]"," "," "," "]
["Amortized Cost",{"v":14382,"d":"14,382 "},{"v":2497,"d":"2,497 "}," "]
["Gross Unrealized Gains",{"v":13,"d":"13 "},{"v":0,"d":"0 "}," "]
["Gross Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Estimated Fair Value",{"v":14395,"d":"14,395 "},{"v":2497,"d":"2,497 "}," "]
["Certificates of deposit"," "," "," "]
["Cash equivalents:"," "," "," "]
["Amortized Cost",{"v":3960,"d":"3,960 "},{"v":0,"d":"0 "}," "]
["Gross Unrealized Gains",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Gross Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Estimated Fair Value",{"v":3960,"d":"3,960 "},{"v":0,"d":"0 "}," "]
["Debt Securities, Available-for-Sale [Abstract]"," "," "," "]
["Amortized Cost",{"v":84645,"d":"84,645 "},{"v":62017,"d":"62,017 "}," "]
["Gross Unrealized Gains",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Gross Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}," "]
["Estimated Fair Value",{"v":84645,"d":"84,645 "},{"v":62017,"d":"62,017 "}," "]
["U.S. government agencies securities"," "," "," "]
["Debt Securities, Available-for-Sale [Abstract]"," "," "," "]
["Amortized Cost",{"v":60536,"d":"60,536 "},{"v":46527,"d":"46,527 "}," "]
["Gross Unrealized Gains",{"v":76,"d":"76 "},{"v":5,"d":"5 "}," "]
["Gross Unrealized Losses",{"v":-155,"d":"(155)"},{"v":-104,"d":"(104)"}," "]
["Estimated Fair Value",{"v":60457,"d":"60,457 "},{"v":46428,"d":"46,428 "}," "]
["Corporate debt securities"," "," "," "]
["Debt Securities, Available-for-Sale [Abstract]"," "," "," "]
["Amortized Cost",{"v":331331,"d":"331,331 "},{"v":310557,"d":"310,557 "}," "]
["Gross Unrealized Gains",{"v":679,"d":"679 "},{"v":64,"d":"64 "}," "]
["Gross Unrealized Losses",{"v":-319,"d":"(319)"},{"v":-526,"d":"(526)"}," "]
["Estimated Fair Value",{"v":331691,"d":"$ 331,691"},{"v":310095,"d":"$ 310,095"}," "]

{"sheet":"Cash Equivalents and Marketab_4","index":36,"n_rows":9,"n_cols":3,"rows_kept":9}
["Cash Equivalents and Marketable Securities - Available-for Sale Debt Securities by Contractual Maturity (Details) - Debt Securities, Available-For-Sale, Excluding Money Market Accounts - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024"]
["Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]"," "," "]
["AFS debt maturities, within one year, amortized cost",{"v":494233,"d":"$ 494,233"},{"v":514747,"d":"$ 514,747"}]
["AFS debt maturities, after one year through five years, amortized cost",{"v":104706,"d":"104,706 "},{"v":69034,"d":"69,034 "}]
["Amortized Cost",{"v":598939,"d":"598,939 "},{"v":583781,"d":"583,781 "}]
["Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]"," "," "]
["AFS debt maturities, within one year, fair value",{"v":494937,"d":"494,937 "},{"v":514484,"d":"514,484 "}]
["AFS debt maturities, after one year through five years, fair value",{"v":104296,"d":"104,296 "},{"v":68736,"d":"68,736 "}]
["AFS debt maturities, total fair value",{"v":599233,"d":"$ 599,233"},{"v":583220,"d":"$ 583,220"}]

{"sheet":"Cash Equivalents and Marketab_5","index":37,"n_rows":40,"n_cols":3,"rows_kept":40}
["Cash Equivalents and Marketable Securities - Available-for-Sale Marketable Securities, Fair Value and Unrealized Losses Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024"]
["Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]"," "," "]
["AFS, Less Than 12 Months, Unrealized Losses",{"v":-474,"d":"$ (474)"},{"v":-590,"d":"$ (590)"}]
["AFS, Less Than 12 Months, Fair Value",{"v":60061,"d":"60,061 "},{"v":237352,"d":"237,352 "}]
["AFS, 12 Months or Greater, Unrealized Losses",{"v":0,"d":"0 "},{"v":-40,"d":"(40)"}]
["AFS, 12 Months or Greater, Fair Value",{"v":0,"d":"0 "},{"v":35407,"d":"35,407 "}]
["AFS, Total Unrealized Losses",{"v":-474,"d":"(474)"},{"v":-630,"d":"(630)"}]
["AFS, Total Fair Value",{"v":60061,"d":"60,061 "},{"v":272759,"d":"272,759 "}]
["U.S. treasury securities"," "," "]
["Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]"," "," "]
["AFS, Less Than 12 Months, Unrealized Losses"," ",{"v":0,"d":"0 "}]
["AFS, Less Than 12 Months, Fair Value"," ",{"v":2497,"d":"2,497 "}]
["AFS, 12 Months or Greater, Unrealized Losses"," ",{"v":0,"d":"0 "}]
["AFS, 12 Months or Greater, Fair Value"," ",{"v":0,"d":"0 "}]
["AFS, Total Unrealized Losses"," ",{"v":0,"d":"0 "}]
["AFS, Total Fair Value"," ",{"v":2497,"d":"2,497 "}]
["U.S. government agencies securities"," "," "]
["Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]"," "," "]
["AFS, Less Than 12 Months, Unrealized Losses",{"v":-155,"d":"(155)"},{"v":-99,"d":"(99)"}]
["AFS, Less Than 12 Months, Fair Value",{"v":18817,"d":"18,817 "},{"v":33890,"d":"33,890 "}]
["AFS, 12 Months or Greater, Unrealized Losses",{"v":0,"d":"0 "},{"v":-6,"d":"(6)"}]
["AFS, 12 Months or Greater, Fair Value",{"v":0,"d":"0 "},{"v":7749,"d":"7,749 "}]
["AFS, Total Unrealized Losses",{"v":-155,"d":"(155)"},{"v":-105,"d":"(105)"}]
["AFS, Total Fair Value",{"v":18817,"d":"18,817 "},{"v":41639,"d":"41,639 "}]
["Commercial paper"," "," "]
["Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]"," "," "]
["AFS, Less Than 12 Months, Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["AFS, Less Than 12 Months, Fair Value",{"v":3517,"d":"3,517 "},{"v":4058,"d":"4,058 "}]
["AFS, 12 Months or Greater, Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["AFS, 12 Months or Greater, Fair Value",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["AFS, Total Unrealized Losses",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["AFS, Total Fair Value",{"v":3517,"d":"3,517 "},{"v":4058,"d":"4,058 "}]
["Corporate debt securities"," "," "]
["Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]"," "," "]
["AFS, Less Than 12 Months, Unrealized Losses",{"v":-319,"d":"(319)"},{"v":-491,"d":"(491)"}]
["AFS, Less Than 12 Months, Fair Value",{"v":37727,"d":"37,727 "},{"v":196907,"d":"196,907 "}]
["AFS, 12 Months or Greater, Unrealized Losses",{"v":0,"d":"0 "},{"v":-34,"d":"(34)"}]
["AFS, 12 Months or Greater, Fair Value",{"v":0,"d":"0 "},{"v":27658,"d":"27,658 "}]
["AFS, Total Unrealized Losses",{"v":-319,"d":"(319)"},{"v":-525,"d":"(525)"}]
["AFS, Total Fair Value",{"v":37727,"d":"$ 37,727"},{"v":224565,"d":"$ 224,565"}]

{"sheet":"Cash Equivalents and Marketab_6","index":38,"n_rows":3,"n_cols":3,"rows_kept":3}
["Cash Equivalents and Marketable Securities - Narrative (Details) - marketable_security","Jan. 31, 2025","Apr. 30, 2024"]
["Investments, Debt and Equity Securities [Abstract]"," "," "]
["Number of marketable securities in unrealized loss position",{"v":43,"d":"43 "},{"v":219,"d":"219 "}]

{"sheet":"Balance Sheet Details - Propert","index":39,"n_rows":19,"n_cols":3,"rows_kept":19}
["Balance Sheet Details - Property and Equipment, Net (Details) - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024"]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":105537,"d":"$ 105,537"},{"v":103404,"d":"$ 103,404"}]
["Less: accumulated depreciation and amortization",{"v":-23627,"d":"(23,627)"},{"v":-14773,"d":"(14,773)"}]
["Property and equipment, net",{"v":81910,"d":"81,910 "},{"v":88631,"d":"88,631 "}]
["Leasehold improvements"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":82507,"d":"$ 82,507"},{"v":71867,"d":"71,867 "}]
["Computer equipment"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Useful Life","36 months"," "]
["Property and equipment, gross",{"v":6702,"d":"$ 6,702"},{"v":4936,"d":"4,936 "}]
["Office furniture and equipment"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Useful Life","60 months"," "]
["Property and equipment, gross",{"v":15517,"d":"$ 15,517"},{"v":14479,"d":"14,479 "}]
["Capital work-in-progress"," "," "]
["Property, Plant and Equipment [Line Items]"," "," "]
["Property and equipment, gross",{"v":811,"d":"$ 811"},{"v":12122,"d":"$ 12,122"}]

{"sheet":"Balance Sheet Details - Narrati","index":40,"n_rows":4,"n_cols":5,"rows_kept":4,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Balance Sheet Details - Narrative (Details) - USD ($) $ in Millions","3 Months Ended",null,"9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "," "," "," "]
["Depreciation expense",{"v":3.1,"d":"$ 3.1"},{"v":2.9,"d":"$ 2.9"},{"v":8.9,"d":"$ 8.9"},{"v":8.5,"d":"$ 8.5"}]

{"sheet":"Balance Sheet Details - Accrued","index":41,"n_rows":9,"n_cols":3,"rows_kept":9}
["Balance Sheet Details - Accrued Compensation and Employee Benefits (Details) - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "," "]
["Accrued bonus",{"v":32875,"d":"$ 32,875"},{"v":31530,"d":"$ 31,530"}]
["Accrued vacation",{"v":3918,"d":"3,918 "},{"v":4317,"d":"4,317 "}]
["Accrued payroll taxes and benefits",{"v":1959,"d":"1,959 "},{"v":3636,"d":"3,636 "}]
["Accrued commissions",{"v":5116,"d":"5,116 "},{"v":2826,"d":"2,826 "}]
["ESPP contributions",{"v":4596,"d":"4,596 "},{"v":1409,"d":"1,409 "}]
["Other",{"v":263,"d":"263 "},{"v":545,"d":"545 "}]
["Accrued compensation and employee benefits",{"v":48727,"d":"$ 48,727"},{"v":44263,"d":"$ 44,263"}]

{"sheet":"Balance Sheet Details - Accru_2","index":42,"n_rows":9,"n_cols":3,"rows_kept":9}
["Balance Sheet Details - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands","Jan. 31, 2025","Apr. 30, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "," "]
["Accrued general expenses",{"v":3678,"d":"$ 3,678"},{"v":2783,"d":"$ 2,783"}]
["Operating lease liabilities, current",{"v":4490,"d":"4,490 "},{"v":3226,"d":"3,226 "}]
["Accrued professional services",{"v":7008,"d":"7,008 "},{"v":2082,"d":"2,082 "}]
["Accrued cloud hosting services",{"v":6687,"d":"6,687 "},{"v":643,"d":"643 "}]
["Accrued taxes payable",{"v":2744,"d":"2,744 "},{"v":621,"d":"621 "}]
["Other",{"v":3021,"d":"3,021 "},{"v":171,"d":"171 "}]
["Accrued and other current liabilities",{"v":27628,"d":"$ 27,628"},{"v":9526,"d":"$ 9,526"}]

{"sheet":"Commitments and Contingencies (","index":43,"n_rows":34,"n_cols":16,"rows_kept":34,"merged":[[0,0,1,0],[0,3,0,4],[0,5,0,6]]}
["Commitments and Contingencies (Details) $ in Millions, € in Billions",null,"1 Months Ended","3 Months Ended",null,"9 Months Ended",null,"25 Months Ended"]
[null,"Feb. 15, 2023 plaintiff officer_and_director","Feb. 29, 2020","Jan. 31, 2025 USD ($)","Jan. 31, 2024 USD ($) phase","Jan. 31, 2025 USD ($)","Jan. 31, 2024 USD ($) phase","Jun. 28, 2024 claim","Jul. 31, 2024 phase","Apr. 30, 2024 USD ($)","Feb. 27, 2024 EUR (€)","Oct. 31, 2023 phase","Apr. 30, 2023 phase","Oct. 31, 2022 phase","Jan. 31, 2022 phase","Aug. 25, 2021 ft²"]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Purchase commitment, incurred cost"," "," ",{"v":31.9,"d":"$ 31.9"},{"v":8.6,"d":"$ 8.6"},{"v":76.7,"d":"$ 76.7"},{"v":24.9,"d":"$ 24.9"}," "," "," "," "," "," "," "," "," "]
["Lease, area under lease | ft²"," "," "," "," "," "," "," "," "," "," "," "," "," "," ",{"v":283015,"d":"283,015 "}]
["Lease, number of phases | phase"," "," "," ",{"v":6,"d":"6 "}," ",{"v":6,"d":"6 "}," ",{"v":7,"d":"7 "}," "," ",{"v":5,"d":"5 "},{"v":4,"d":"4 "},{"v":3,"d":"3 "},{"v":2,"d":"2 "}," "]
["Increase in lease liability"," "," ",41.3," "," "," "," "," "," "," "," "," "," "," "," "]
["Increase in right-of-use asset"," "," ",4.4," "," "," "," "," "," "," "," "," "," "," "," "]
["The Reckstin Family Trust v. C3.ai, Inc. | Settled Litigation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Number of additional plaintiffs | plaintiff",{"v":3,"d":"3 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Number of current and former officers and directors | officer_and_director",{"v":4,"d":"4 "}," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Suri V. Siebel Et Al., Rabasca V. Siebel Et Al., Vo V. Siebel Et Al., Lanfair V. Siebel Et Al., Pankow V. Seibel Et Al., Rosenfeld V. Siebel Et Al. | Pending Litigation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Number of actions filed | claim"," "," "," "," "," "," ",{"v":6,"d":"6 "}," "," "," "," "," "," "," "," "]
["Enel Global Services S.R.L And Any Involved Corporate Affiliates (\"Enel\") | Pending Litigation"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Unrecorded amount | €"," "," "," "," "," "," "," "," "," ",{"v":2.1,"d":"€ 2.1"}," "," "," "," "," "]
["C3.ai DTI Grants Program"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Grants, payment period"," ","5 years"," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Grants, potential remaining contributions"," "," ",31.6," ",31.6," "," "," ",{"v":31.6,"d":"$ 31.6"}," "," "," "," "," "," "]
["Cloud Hosting Services"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Remaining contractual commitment"," "," ",438.1," ",438.1," "," "," "," "," "," "," "," "," "," "]
["Professional services"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Remaining contractual commitment"," "," ",{"v":93.2,"d":"$ 93.2"}," ",{"v":93.2,"d":"$ 93.2"}," "," "," "," "," "," "," "," "," "," "]
["Professional services | Minimum"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Purchase commitment, term"," "," "," "," ","1 year"," "," "," "," "," "," "," "," "," "," "]
["Professional services | Maximum"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Long-term Purchase Commitment [Line Items]"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "]
["Purchase commitment, term"," "," "," "," ","5 years"," "," "," "," "," "," "," "," "," "," "]

{"sheet":"Stockholders' Equity (Details)","index":44,"n_rows":21,"n_cols":2,"rows_kept":21,"merged":[[0,0,1,0]]}
["Stockholders' Equity (Details)","9 Months Ended"]
[null,"Jan. 31, 2025 vote $ / shares shares"]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "]
["Preferred stock, shares authorized (in shares)",{"v":200000000,"d":"200,000,000 "}]
["Preferred stock, par value (in dollars per share) | $ / shares",{"v":0.001,"d":"$ 0.001"}]
["Preferred stock, shares issued (in shares)",{"v":0,"d":"0 "}]
["Preferred stock, shares outstanding (in shares)",{"v":0,"d":"0 "}]
["Common stock, conversion basis of stock",{"v":1,"d":"1 "}]
["Automatic conversion period, following the death or incapacity of Mr. Siebel","6 months"]
["Automatic conversion period, following the date Mr. Siebel no longer providing services","6 months"]
["Automatic conversion, anniversary period, if circumstances met","20 years"]
["Class A Common Stock"," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "]
["Common stock, shares authorized (in shares)",{"v":1000000000,"d":"1,000,000,000 "}]
["Voting rights, number of votes for each share | vote",{"v":1,"d":"1 "}]
["Common stock, par value (in dollars per share) | $ / shares",{"v":0.001,"d":"$ 0.001"}]
["Class B Common Stock"," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "]
["Common stock, shares authorized (in shares)",{"v":3500000,"d":"3,500,000 "}]
["Voting rights, number of votes for each share | vote",{"v":50,"d":"50 "}]
["Common stock, par value (in dollars per share) | $ / shares",{"v":0.001,"d":"$ 0.001"}]

{"sheet":"Stock-Based Compensation - Narr","index":45,"n_rows":71,"n_cols":8,"rows_kept":71,"merged":[[0,0,1,0],[0,2,0,3],[0,4,0,5]]}
["Stock-Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands",null,"3 Months Ended",null,"9 Months Ended"]
[null,"Nov. 27, 2020 USD ($) period shares","Jan. 31, 2025 USD ($) $ / shares","Jan. 31, 2024 USD ($)","Jan. 31, 2025 USD ($) $ / shares shares","Jan. 31, 2024 USD ($) shares","May 01, 2024","Jul. 31, 2022 shares"]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Total stock-based compensation expense"," ",{"v":62652,"d":"$ 62,652"},{"v":54983,"d":"$ 54,983"},{"v":174373,"d":"$ 174,373"},{"v":159032,"d":"$ 159,032"}," "," "]
["Risk-free interest rate"," "," "," ",{"v":0.036,"d":"3.60%"},{"v":0.039,"d":"3.90%"}," "," "]
["Expected dividend yield"," "," "," ",{"v":0,"d":"0%"},{"v":0,"d":"0%"}," "," "]
["Expected volatility"," "," "," ",{"v":0.662,"d":"66.20%"},{"v":0.635,"d":"63.50%"}," "," "]
["Accrued bonus"," ",{"v":32900,"d":"32,900 "}," ",{"v":32900,"d":"$ 32,900"}," "," "," "]
["Stock options"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Unrecognized compensation cost"," ",{"v":65400,"d":"65,400 "}," ",{"v":65400,"d":"$ 65,400"}," "," "," "]
["Unrecognized compensation cost, weighted-average recognition period"," "," "," ","2 years 1 month 6 days"," "," "," "]
["RSUs"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Vesting period"," "," "," ","5 years"," "," "," "]
["Unrecognized compensation cost, weighted-average recognition period"," "," "," ","3 years 9 months 18 days"," "," "," "]
["Unrecognized stock-based compensation expense"," ",{"v":579800,"d":"$ 579,800"}," ",{"v":579800,"d":"$ 579,800"}," "," "," "]
["Granted, non-option (in shares) | shares"," "," "," ",{"v":12676000,"d":"12,676,000 "}," "," "," "]
["RSUs | Share-Based Payment Arrangement, Tranche One"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Vesting percentages"," "," "," ",{"v":0.2,"d":"20%"}," "," "," "]
["Vesting period"," "," "," ","1 year"," "," "," "]
["RSUs | Share-Based Payment Arrangement, Tranche Two"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Vesting percentages"," "," "," ",{"v":0.05,"d":"5%"}," "," "," "]
["Performance Shares"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Maximum shares authorized (in shares) | shares"," "," "," "," "," "," ",{"v":1700000,"d":"1,700,000 "}]
["Total stock-based compensation expense"," "," "," ",{"v":3100,"d":"$ 3,100"}," "," "," "]
["Stock price (in dollars per share) | $ / shares"," ",{"v":12.9,"d":"$ 12.90"}," ",{"v":12.9,"d":"$ 12.90"}," "," "," "]
["Risk-free interest rate"," "," "," ",{"v":0.037,"d":"3.70%"}," "," "," "]
["Expected dividend yield"," "," "," ",{"v":0,"d":"0%"}," "," "," "]
["Expected volatility"," "," "," ",{"v":0.514,"d":"51.40%"}," "," "," "]
["2020 Incentive Plan | Stock options"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Expiration period (in years)"," "," "," ","10 years"," "," "," "]
["2020 Incentive Plan | Stock options | Share-Based Payment Arrangement, Tranche One"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Vesting percentages"," "," "," ",{"v":0.2,"d":"20%"}," "," "," "]
["Vesting period"," "," "," ","1 year"," "," "," "]
["2020 Incentive Plan | Stock options | Share-Based Payment Arrangement, Tranche Two"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Vesting percentages"," "," "," ",{"v":0.02,"d":"2%"}," "," "," "]
["Vesting period"," "," "," ","4 years"," "," "," "]
["2020 Employee Stock Purchase Plan | ESPP"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Total stock-based compensation expense"," "," "," ",{"v":4400,"d":"$ 4,400"},{"v":4300,"d":"$ 4,300"}," "," "]
["Expected dividend yield"," "," "," ",{"v":0,"d":"0%"},{"v":0,"d":"0%"}," "," "]
["Unrecognized stock-based compensation expense"," ",{"v":5700,"d":"$ 5,700"}," ",{"v":5700,"d":"$ 5,700"}," "," "," "]
["Percentage of employee earnings participation (up to)",{"v":0.15,"d":"15%"}," "," "," "," "," "," "]
["Initial offering period (in months)","24 months"," "," "," "," "," "," "]
["Number of purchase periods | period",{"v":4,"d":"4 "}," "," "," "," "," "," "]
["Purchase period (in months)","6 months"," "," "," "," "," "," "]
["Annual Bonus Program And Retention Bonus Program | RSUs"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Total stock-based compensation expense"," "," "," ",{"v":37600,"d":"$ 37,600"}," "," "," "]
["Common Class A and Common Class B | 2020 Incentive Plan"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Automatic increase to shares reserved for future issuance, percent of total shares"," "," "," "," "," ",{"v":0.07,"d":"7%"}," "]
["Common Class A and Common Class B | 2020 Employee Stock Purchase Plan | ESPP"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Automatic increase to shares reserved for future issuance, percent of total shares"," "," "," "," "," ",{"v":0.01,"d":"1%"}," "]
["Class A Common Stock | Restricted Stock"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Granted, non-option (in shares) | shares"," "," "," ",{"v":751927,"d":"751,927 "},{"v":532842,"d":"532,842 "}," "," "]
["Class A Common Stock | 2020 Employee Stock Purchase Plan | ESPP"," "," "," "," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "," "," "," "]
["Shares reserved for future issuance (in shares) | shares",{"v":3000000,"d":"3,000,000 "}," "," "," "," "," "," "]
["Shares purchased (in shares) | shares",{"v":2500,"d":"2,500 "}," "," "," "," "," "," "]
["Shares purchased",{"v":25,"d":"$ 25"}," "," "," "," "," "," "]
["Fair market value (as a percent)",{"v":0.85,"d":"85%"}," "," "," "," "," "," "]

{"sheet":"Stock-Based Compensation - Stoc","index":46,"n_rows":28,"n_cols":3,"rows_kept":28,"merged":[[0,0,1,0]]}
["Stock-Based Compensation - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands","9 Months Ended","12 Months Ended"]
[null,"Jan. 31, 2025 USD ($) $ / shares shares","Apr. 30, 2024 USD ($) $ / shares shares"]
["Number of Stock Options Outstanding"," "," "]
["Balance at beginning of period (in shares) | shares",{"v":31328,"d":"31,328 "}," "]
["Options granted (in shares) | shares",{"v":1187,"d":"1,187 "}," "]
["Options exercised (in shares) | shares",{"v":-3169,"d":"(3,169)"}," "]
["Options cancelled (in shares) | shares",{"v":-540,"d":"(540)"}," "]
["Balance at end of period (in shares) | shares",{"v":28806,"d":"28,806 "},{"v":31328,"d":"31,328 "}]
["Vested and exercisable at end of period (in shares) | shares",{"v":23724,"d":"23,724 "}," "]
["Vested and expected to vest at end of period (in shares) | shares",{"v":28806,"d":"28,806 "}," "]
["Weighted Average Exercise Price"," "," "]
["Balance at beginning of period (in dollars per share) | $ / shares",{"v":13.97,"d":"$ 13.97"}," "]
["Options granted (in dollars per share) | $ / shares",23.43," "]
["Options exercised (in dollars per share) | $ / shares",33.66," "]
["Options cancelled (in dollars per share) | $ / shares",26.53," "]
["Balance at end of period (in dollars per share) | $ / shares",15.09,{"v":13.97,"d":"$ 13.97"}]
["Vested and exercisable at end of period (in dollars per share) | $ / shares",12.17," "]
["Vested and expected to vest at end of period (in dollars per share) | $ / shares",{"v":15.09,"d":"$ 15.09"}," "]
["Weighted Average Remaining Contractual Life (years)"," "," "]
["Balance at beginning of period","5 years 2 months 23 days","5 years 8 months 4 days"]
["Balance at end of period","5 years 2 months 23 days","5 years 8 months 4 days"]
["Vested and exercisable at end of period","4 years 9 months 10 days"," "]
["Vested and expected to vest at end of period","5 years 2 months 23 days"," "]
["Aggregate Intrinsic Value"," "," "]
["Balance at beginning of period | $",{"v":468385,"d":"$ 468,385"},{"v":268167,"d":"$ 268,167"}]
["Balance at end of period | $",{"v":468385,"d":"468,385 "},{"v":268167,"d":"$ 268,167"}]
["Vested and exercisable at end of period | $",{"v":455027,"d":"455,027 "}," "]
["Vested and expected to vest at end of period | $",{"v":468385,"d":"$ 468,385"}," "]

{"sheet":"Stock-Based Compensation - Valu","index":47,"n_rows":7,"n_cols":3,"rows_kept":7,"merged":[[0,0,1,0],[0,1,0,2]]}
["Stock-Based Compensation - Valuation Assumptions (Details)","9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024"]
["Share-Based Payment Arrangement [Abstract]"," "," "]
["Expected dividend yield",{"v":0,"d":"0%"},{"v":0,"d":"0%"}]
["Expected volatility",{"v":0.662,"d":"66.20%"},{"v":0.635,"d":"63.50%"}]
["Expected term (years)","6 years 1 month 6 days","6 years"]
["Risk-free interest rate",{"v":0.036,"d":"3.60%"},{"v":0.039,"d":"3.90%"}]

{"sheet":"Stock-Based Compensation - Rest","index":48,"n_rows":14,"n_cols":2,"rows_kept":14,"merged":[[0,0,1,0]]}
["Stock-Based Compensation - Restricted Stock Unit Activity (Details) - RSUs shares in Thousands","9 Months Ended"]
[null,"Jan. 31, 2025 $ / shares shares"]
["Number of RSUs"," "]
["Unvested Balance at beginning of period (in shares) | shares",{"v":19283,"d":"19,283 "}]
["RSUs granted (in shares) | shares",{"v":12676,"d":"12,676 "}]
["RSUs vested (in shares) | shares",{"v":-5381,"d":"(5,381)"}]
["RSUs forfeited (in shares) | shares",{"v":-2999,"d":"(2,999)"}]
["Unvested Balance at end of period (in shares) | shares",{"v":23579,"d":"23,579 "}]
["Weighted Average Grant Date Fair Value Per Share"," "]
["Unvested Balance at beginning of period (in dollars per share) | $ / shares",{"v":24.26,"d":"$ 24.26"}]
["RSUs granted (in dollars per share) | $ / shares",29.51]
["RSUs vested (in dollars per share) | $ / shares",27.54]
["RSUs forfeited (in dollars per share) | $ / shares",27.46]
["Unvested Balance at end of period (in dollars per share) | $ / shares",{"v":26.41,"d":"$ 26.41"}]

{"sheet":"Stock-Based Compensation - Va_2","index":49,"n_rows":18,"n_cols":3,"rows_kept":18,"merged":[[0,0,1,0],[0,1,0,2]]}
["Stock-Based Compensation - Valuation Assumption, 2020 ESPP (Details)","9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024"]
["Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]"," "," "]
["Expected dividend yield",{"v":0,"d":"0%"},{"v":0,"d":"0%"}]
["Expected term (years)","6 years 1 month 6 days","6 years"]
["ESPP | 2020 Employee Stock Purchase Plan"," "," "]
["Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]"," "," "]
["Expected dividend yield",{"v":0,"d":"0%"},{"v":0,"d":"0%"}]
["Expected volatility, minimum",{"v":0.562,"d":"56.20%"},{"v":0.64,"d":"64%"}]
["Expected volatility, maximum",{"v":0.753,"d":"75.30%"},{"v":0.701,"d":"70.10%"}]
["Risk-free interest rate, minimum",{"v":0.036,"d":"3.60%"},{"v":0.05,"d":"5%"}]
["Risk-free interest rate, maximum",{"v":0.046,"d":"4.60%"},{"v":0.055,"d":"5.50%"}]
["ESPP | 2020 Employee Stock Purchase Plan | Minimum"," "," "]
["Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]"," "," "]
["Expected term (years)","6 months","6 months"]
["ESPP | 2020 Employee Stock Purchase Plan | Maximum"," "," "]
["Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]"," "," "]
["Expected term (years)","2 years","2 years"]

{"sheet":"Stock-Based Compensation - St_2","index":50,"n_rows":19,"n_cols":5,"rows_kept":19,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "]
["Total stock-based compensation expense",{"v":62652,"d":"$ 62,652"},{"v":54983,"d":"$ 54,983"},{"v":174373,"d":"$ 174,373"},{"v":159032,"d":"$ 159,032"}]
["Cost of revenue | Subscription"," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "]
["Total stock-based compensation expense",{"v":8563,"d":"8,563 "},{"v":8674,"d":"8,674 "},{"v":24084,"d":"24,084 "},{"v":25244,"d":"25,244 "}]
["Cost of revenue | Professional services"," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "]
["Total stock-based compensation expense",{"v":941,"d":"941 "},{"v":309,"d":"309 "},{"v":2139,"d":"2,139 "},{"v":1248,"d":"1,248 "}]
["Sales and marketing"," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "]
["Total stock-based compensation expense",{"v":21860,"d":"21,860 "},{"v":17528,"d":"17,528 "},{"v":61495,"d":"61,495 "},{"v":52533,"d":"52,533 "}]
["Research and development"," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "]
["Total stock-based compensation expense",{"v":19896,"d":"19,896 "},{"v":18757,"d":"18,757 "},{"v":56326,"d":"56,326 "},{"v":52475,"d":"52,475 "}]
["General and administrative"," "," "," "," "]
["Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"," "," "," "," "]
["Total stock-based compensation expense",{"v":11392,"d":"$ 11,392"},{"v":9715,"d":"$ 9,715"},{"v":30329,"d":"$ 30,329"},{"v":27532,"d":"$ 27,532"}]

{"sheet":"Income Taxes (Details)","index":51,"n_rows":4,"n_cols":5,"rows_kept":4,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Income Taxes (Details) - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Income Tax Disclosure [Abstract]"," "," "," "," "]
["Provision for income taxes",{"v":336,"d":"$ 336"},{"v":489,"d":"$ 489"},{"v":865,"d":"$ 865"},{"v":863,"d":"$ 863"}]

{"sheet":"Net Loss Per Share Attributab_3","index":52,"n_rows":10,"n_cols":5,"rows_kept":10,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024","Jan. 31, 2025","Jan. 31, 2024"]
["Numerator"," "," "," "," "]
["Net loss attributable to common stockholders",{"v":-80201,"d":"$ (80,201)"},{"v":-72631,"d":"$ (72,631)"},{"v":-209000,"d":"$ (209,000)"},{"v":-206769,"d":"$ (206,769)"}]
["Denominator"," "," "," "," "]
["Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)",{"v":130382,"d":"130,382 "},{"v":120486,"d":"120,486 "},{"v":127752,"d":"127,752 "},{"v":118259,"d":"118,259 "}]
["Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)",{"v":130382,"d":"130,382 "},{"v":120486,"d":"120,486 "},{"v":127752,"d":"127,752 "},{"v":118259,"d":"118,259 "}]
["Basic and diluted net loss per share attributable to common stockholders"," "," "," "," "]
["Basic net loss per Class A and Class B common shares (in dollars per share)",{"v":-0.62,"d":"$ (0.62)"},{"v":-0.6,"d":"$ (0.60)"},{"v":-1.64,"d":"$ (1.64)"},{"v":-1.75,"d":"$ (1.75)"}]
["Diluted net loss per Class A and Class B common shares (in dollars per share)",{"v":-0.62,"d":"$ (0.62)"},{"v":-0.6,"d":"$ (0.60)"},{"v":-1.64,"d":"$ (1.64)"},{"v":-1.75,"d":"$ (1.75)"}]

{"sheet":"Net Loss Per Share Attributab_4","index":53,"n_rows":11,"n_cols":3,"rows_kept":11,"merged":[[0,0,1,0],[0,1,0,2]]}
["Net Loss Per Share Attributable to Common Stockholders - Potential Shares Excluded From Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands","9 Months Ended"]
[null,"Jan. 31, 2025","Jan. 31, 2024"]
["Stock options"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Potentially antidilutive shares excluded from computation of net loss per share (in shares)",{"v":28806,"d":"28,806 "},{"v":32103,"d":"32,103 "}]
["RSUs"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Potentially antidilutive shares excluded from computation of net loss per share (in shares)",{"v":23579,"d":"23,579 "},{"v":20908,"d":"20,908 "}]
["ESPP"," "," "]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "]
["Potentially antidilutive shares excluded from computation of net loss per share (in shares)",{"v":975,"d":"975 "},{"v":1102,"d":"1,102 "}]

{"sheet":"Related Party Transactions (Det","index":54,"n_rows":36,"n_cols":8,"rows_kept":36,"merged":[[0,0,1,1],[0,3,0,4],[0,5,0,6],[34,0,34,6],[35,0,35,6]]}
["Related Party Transactions (Details)",null,null,"3 Months Ended",null,"9 Months Ended"]
[null,null,"Feb. 21, 2023 USD ($) ft²","Jan. 31, 2025 USD ($)","Jan. 31, 2024 USD ($)","Jan. 31, 2025 USD ($)","Jan. 31, 2024 USD ($)","Aug. 25, 2021 ft² office_tower"]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Total revenue",null," ",{"v":98782000,"d":"$ 98,782,000"},{"v":78401000,"d":"$ 78,401,000"},{"v":280333000,"d":"$ 280,333,000"},{"v":223992000,"d":"$ 223,992,000"}," "]
["Sales and marketing expenses","[1]"," ",{"v":61201000,"d":"61,201,000 "},{"v":57140000,"d":"57,140,000 "},{"v":168969000,"d":"168,969,000 "},{"v":150920000,"d":"150,920,000 "}," "]
["Subleased space area (in square feet) | ft²",null,{"v":3130,"d":"3,130 "}," "," "," "," ",{"v":283013,"d":"283,013 "}]
["Number of office towers | office_tower",null," "," "," "," "," ",{"v":2,"d":"2 "}]
["Automatic renewal term (in years)",null,"1 year"," "," "," "," "," "]
["Monthly base rent",null,{"v":8608,"d":"$ 8,608"}," "," "," "," "," "]
["Subscription",null," "," "," "," "," "," "]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Total revenue","[2]"," ",{"v":85679000,"d":"85,679,000 "},{"v":70400000,"d":"70,400,000 "},{"v":240297000,"d":"240,297,000 "},{"v":198201000,"d":"198,201,000 "}," "]
["Professional services",null," "," "," "," "," "," "]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Total revenue","[3]"," ",{"v":13103000,"d":"$ 13,103,000"},{"v":8001000,"d":"$ 8,001,000"},{"v":40036000,"d":"$ 40,036,000"},{"v":25791000,"d":"25,791,000 "}," "]
["Related Party",null," "," "," "," "," "," "]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Sales and marketing expenses",null," "," "," "," ",{"v":810000,"d":"810,000 "}," "]
["Related Party | Subscription",null," "," "," "," "," "," "]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Total revenue",null," "," "," "," ",{"v":10581000,"d":"10,581,000 "}," "]
["Related Party | Professional services",null," "," "," "," "," "," "]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Total revenue",null," "," "," "," ",{"v":5804000,"d":"5,804,000 "}," "]
["Related Party | Software Subscription Agreement | Baker Hughes Company",null," "," "," "," "," "," "]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Sales and marketing expenses",null," "," "," "," ",{"v":800000,"d":"800,000 "}," "]
["Deferred costs, sales commissions, amortization",null," "," "," "," ",{"v":800000,"d":"800,000 "}," "]
["Related Party | Software Subscription Agreement | Baker Hughes Company | Subscription",null," "," "," "," "," "," "]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Total revenue",null," "," "," "," ",{"v":10600000,"d":"10,600,000 "}," "]
["Related Party | Software Subscription Agreement | Baker Hughes Company | Professional services",null," "," "," "," "," "," "]
["Related Party Transaction [Line Items]",null," "," "," "," "," "," "]
["Total revenue",null," "," "," "," ",{"v":5800000,"d":"$ 5,800,000"}," "]
[]
["[1]Including related party sales and marketing expense of $810 for the nine months ended January 31, 2024.[2]Including related party revenue of $10,581 for the nine months ended January 31, 2024.[3]Including related party revenue of $5,804 for the nine months ended January 31, 2024."]